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ABSTRACT 
Development of a Thermoresponsive and Chemically Crosslinkable Hydrogel System for 
Craniofacial Bone Tissue Engineering 
by 
Eleftheria Leda Klouda 
A novel injectable hydrogel system for cell delivery in craniofacial bone tissue 
engineering was developed in this work. The hydrogel employs a dual solidification 
mechanism by containing units that gel upon temperature increase to physiological 
temperature and groups that allow for covalent crosslinking. The successful synthesis of 
macromers for hydrogel fabrication was demonstrated and structure-property relations 
were established. The hydrophilic-hydrophobic balance of the macromers was found to 
be an important design criterion towards their resulting thermal gelation properties. When 
tested with cells in vitro, macromers with different molecular compositions, molecular 
weights and transition temperatures were all found to be cytocompatible. The 
introduction of a chemically crosslinkable group in the macromers resulted in hydrogels 
with improved stability. The effect of the addition of these highly reactive groups on cell 
viability was evaluated and parameters that enable viable cell encapsulation in the 
hydro gels were determined. It was shown that there was a dose- and time-dependent 
effect of the macromers on cell viability. Increased degrees of modification were found 
to decrease the thermal transition temperature as well as the cytocompatibility of the 
macromers. Hydrogels were fabricated at physiological temperature upon physical 
gelation and chemical crosslinking with the addition of a thermal free radical initiator 
system. The swelling behavior of the hydro gels was characterized and it was found to be 
controlled by the chemistry of the macromer end group, the concentration of the initiator 
system used, the fabrication interval as well as the incubation temperature and medium. 
In order to evaluate the hydro gels as cell carriers, mesenchymal stems cells were 
encapsulated in the hydro gels over a 21-day period. Cells retained their viability over the 
duration of the study and exhibited markers of osteogenic differentiation when cultured 
with appropriate supplements. These findings hold promise for the use of these hydrogel 
systems for cell encapsulation in tissue engineering applications. 
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CHAPTER I 
OBJECTIVE AND SPECIFIC AIMS 
The overall objective of this work is the development of injectable, in situ forming 
hydrogels for application in craniofacial bone tissue engineering. The hydrogel is 
designed to solidify upon injection to the body at physiological temperature, employing 
two independent gelation mechanisms. 
1. Synthesis and characterization of thermally responsive and chemically 
crosslinkable, amphiphilic N-isopropylacrylamide based macromers 
Synthesis of macromers that contain thermally responsive domains and 
chemically modifiable units that allow for covalent crosslinking. 
Evaluation of the effects of macromer composition and hydrophilic-
hydrophobic balance on the thermal gelation characteristics (Le. lower critical 
solution temperature and gel stability). 
Evaluation of the effects of a dual, physical and chemical gelation mechanism 
at physiological temperature employing a chemical initiator system on 
hydrogel stability. 
2 
2. Cytocompatibility evaluation of thermally responsive and chemically 
crosslinkable macromers 
Evaluation of the effects of unmodified macromer molecular composition, 
molecular weight and lower critical solution temperature on in vitro cell 
viability. 
Evaluation of the effect of macromer modification with varying contents of 
(meth)acrylate groups on in vitro cell viability. 
3. Fabrication, characterization and cell encapsulation in thermoresponsive and 
chemically crosslinkable hydrogels 
Evaluation of the effect of fabrication method and incubation temperature on 
the hydrogel swelling characteristics. 
Evaluation of the effect of macromer end group chemistry (acrylate or 
methacrylate group) on in vitro hydrogel swelling and degradation. 
Mesenchymal stem cell encapsulation in the hydrogels and evaluation of in 
vitro cellular viability, osteogenic differentiation and hydrogel mineralization. 
CHAPTER II 
BACKGROUND INFORMATION: INJECTABLE SYSTEMS FOR 
CRANIOFACIAL BONE TISSUE ENGINEERING 
Abstract 
3 
Tissue engineering represents a promising strategy towards the regeneration of 
craniofacial bone defects. This approach relies on the delivery of a scaffold material with 
cells and bioactive factors and can provide significant aid in the healing of compromised 
tissues. The parameters that are important in the design of a biomaterial carrier are 
discussed. Injectable systems are particularly attractive for craniofacial bone defects as 
they can be administered in a minimally invasive manner and can fill irregular cavities, 
two factors that are important due to the unique location and shape of these defects. 
Among injectable, in situ forming hydrogels, thermoresponsive materials utilize 
temperature change as the trigger that determines their gelling behavior without any 
additional external factor. These hydrogels have been interesting for biomedical uses as 
they can swell under physiological conditions and provide the advantage of convenient 
administration. 
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Significance and current treatments of craniofacial bone defects 
Bone loss and possible strategies towards its replacement represent some of the 
most common problems for surgeons nowadays. One particular challenge is represented 
by defects in the skull and facial bones which impose severe functional and aesthetic 
limitations to patients. Craniofacial bone defects can cause facial asymmetry and 
problems in mastication and articulation, depending on the location of the defect 1. 
Furthermore, the protection of the brain and soft cranial and facial tissues may be 
compromised 2. The occurrence of craniofacial defects may result from tumor resection, 
trauma, ischemic or infectious causes as well as congenital and developmental anomalies 
1,2 
Craniofacial bone reconstruction aims at re-establishing form and function, as 
well as minimizing patient morbidity and discomfort 1. Ideally, a bone grafting material 
should be biocompatible and not affect unfavorably its biological environment, perform 
the mechanical and structural function of native bone and promote its healing. Traditional 
treatments include alloplastic materials (non-living) as well as homologous (from the 
same species), heterologous (from a different species) and autologous (from oneself) 
bone grafts 2. Some alloplastic materials that have been used in craniofacial bone 
reconstruction over the past years include aluminum, gold, vitallium (an alloy of cobalt, 
chromium and molybdenum), tantalum, stainless steel, titanium, methylmethacrylate 
resins, polyethylene, silicone elastomers and hydroxyapatite ceramics 2. However, 
limitations inherent in the use of alloplastic materials include biocompatibility issues and 
insufficient response to the mechanical and thermal stress of the physiologic 
5 
environment. Specifically, there is increased probability of inflammatory response, risk 
of infection or neoproliferative reactions. Furthermore, conventional materials are not 
biodegradable and lack the ability to remodel with the host tissues and organs. Another 
important consideration for the material is to be easy to handle and to adapt to the shape 
of the defect 2-4. Biologically active implants such as demineralized bone matrix obtained 
from homologous or heterologous sources have shown potential for reconstructive 
purposes because of their high ability to induce bone growth termed as osteoinductivity 5. 
However, drawbacks include the theoretical risk of disease transmission, possible 
immune rejection, as well as cost. Surgeons often regard autologous bone as the gold 
standard for a grafting material due to its potential for growth and remodeling, as well as 
immunocompatibility. Disadvantages associated with this approach include insufficient 
host tissue for repair of the defect site and possible donor site morbidity 3,6,7. 
A more recent promising approach involves the emerging field of tissue 
engineering for the regeneration of bone defects. As defined by Langer and Vacanti in 
1993: "Tissue Engineering is an interdisciplinary field that applies the principles of 
engineering and life sciences toward the development of biological substitutes that 
restore, maintain, or improve tissue function" 8. 
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Engineering complex craniofacial tissues * 
Tissue engineering strategies rely on the use of cells, bioactive factors, and 
scaffolds or combinations thereof. The scaffold serves the purpose of a delivery vehicle, a 
space-filling agent and can be designed to be biointeractive, i.e. to be able to guide tissue 
regeneration. The field of tissue engineering has made significant advances over the past 
15 years. Interdisciplinary research spanning basic cell biology to nanotechnology 
deepened our understanding of nature and enabled methods of mimicking it to augment 
tissue or even organ function. Research on virtually all types of tissues is being currently 
conducted, and products for cartilage and skin regeneration are already approved for 
commercial use by the Food and Drug Administration of the United States. The 
engineering of more complex tissues remains a challenge, but encouraging results were 
published in the Lancet in 2006, reporting the clinical success of a tissue engineered 
bladder 9. Bladder tissue has distinct properties and is it difficult to restore its function 
with synthetic materials or grafts. Patients' own populations of smooth muscle and 
urothelial cells were expanded in vitro, seeded on bladder-shaped, biodegradable 
scaffolds, and implanted. Functional bladders were observed on patient follow up over a 
period of years, and importantly, no adverse effects on other organs, such as kidney 
problems, were reported. Biopsies taken from the tissue engineered bladders showed an 
architecture and phenotype that adequately resembled the native organs. The authors 
• The following section was included in: J.D. Kretlow, S. Young, L. Klouda, M. Wong and A.G. 
Mikos, Injectable Biomaterials for Regenerating Complex Craniofacial Tissues, Advanced 
materials 21 (2009), 3368-3393 
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concluded that tissue engineering of the complex bladder is possible, however further 
studies are necessary to optimize the procedure for wide clinical use. 
The coordinated regeneration of multiple tissues in the complex craniofacial 
environment requires a deeper understanding of their physiology and their remodeling 
characteristics. One needs to engineer complex tissues with the structural and functional 
characteristics of the native tissue, in a process that is not only biocompatible but also 
interactive with neighboring tissues at the same time. Another challenge lies in the fact 
that one type of tissue can be found in various structures that serve different functions 
and have therefore different properties. For example, the cartilaginous structures found in 
the craniofacial region have very distinct characteristics. It may require a certain 
approach to regenerate the weight-bearing, dense bilaminar structure of cartilage found in 
the temporomandibular joint (TMJ), and quite another to create the delicate elastic 
cartilage found in the ears or nose 10. 
The craniofacial region, including also oral and dental tissues, is composed of 
skin, bone, muscle, cartilage, adipose tissue, tendons, ligaments, salivary glands and 
teeth. Extensive research is conducted on each of these tissues, but few studies focus on 
regeneration of mUltiple tissues in tandem. Recent advances in craniofacial tissue 
engineering, as summarized by Mao et al 3, include integrated bone and cartilage layers 
for the temporomandibular joint (TMJ) condyle, various elements of the periodontium, 
craniofacial bone, cranial suture-like structures as well as adipose tissue. 
Tissue engineering of composite tissues such as of those found in the craniofacial 
region is a demanding task. One needs to account for multiple cellular phenotypes and 
8 
find a way to enhance their interactions towards tissue repair, possibly stimulating their 
behavior by supplying bioactive factors. Furthermore, the problem of vascularization 
must be solved since most tissues are strongly dependent on blood supply for growth. 
Creating stratified tissue architectures and achieving the physiological structure-function 
properties of the final tissues is the ultimate goal. The choice of a tissue engineering 
scaffold can significantly aid in this process, not only being a delivery vehicle for the 
cells and bioactive factors but also with its ability to interact and guide tissue growth. 
Cell-material interactions and mass transport are only some of the important parameters 
that need to be incorporated into the design. Additionally, one needs to consider that the 
location and form of craniofacial tissues requires special treatment. For this delicate 
region, also the aesthetic effect is important and there should ideally be minimal scar 
formation. 
Craniofacial Bone 
Tissue engineering of the cranial and facial bone is a promising technique towards 
the functional restoration of this tissue. Craniofacial bone serves as a protective barrier to 
the intercranial structures and maintains the shape of the head. Bone is a highly 
vascularized and cellular tissue. The extracellular matrix of bone consists of an organic 
component, mainly collagen, and an inorganic component. This mineral component 
provides the mechanical strength of the matrix 11. Approaches towards tissue engineering 
of bone are numerous, and much progress has been reported in that area. It is desired that 
bone tissue engineering constructs are osteoconductive, i.e. are allowing the migration of 
cells from the surrounding bone tissues and the sprouting of existing blood vessels, and 
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also osteoinductive, meaning that they encourage the formation of new bone by inducing 
cellular differentiation and mineralization. Review articles on bone tissue engineering 
considerations have been extensively published 12-16. The Mikos group and other 
researchers have been utilizing a synthetic biomaterial strategy, usually in conjunction 
with growth factors and/or cellular delivery. Synthetic polymers, ceramics or composites 
thereof belong to the biomaterials mostly investigated for bone tissue engineering; many 
of these systems being injectable as well. It is suggested that osteogenesis is strongly 
dependent on angiogenesis 17. Besides the facilitated transport of nutrients, oxygen and 
minerals, blood vessels stimulate bone morphogenesis due to the osteogenic effects of 
vascular cells 18. This association has led many researchers to investigate the 
incorporation of angiogenic growth factors into bone tissue engineering models 19-21. Also 
potent osteogenic factors have been identified, one prominent example being bone 
morphogenetic protein 2 (BMP-2). This growth factor has been shown to induce ectopic 
bone formation, i.e. in sites where bone would normally not grow 22, 23. As our 
understanding of bone cell biology and development deepens, new frontiers open up in 
tissue engineering. A breakthrough was the identification of mesenchymal stem cells, the 
progenitor cells bone tissue derives from, and their isolation from mUltiple sites in the 
body. Factors that enhance the bone-forming capacity of these cells, found in their 
biomechanical and biochemical environment, are currently heavily examined 24-27. 
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Cell delivery for engineering complex craniofacial tissues 
The delivery of cells to a defect is a means to accelerate the healing process as the 
body would not have to rely on host cells being recruited to that site. The cell source and 
type is a topic of much discussion and research over the past decades, and approaches 
using xenogeneic, allogeneic or autologous cells have been made. There are advantages 
and disadvantages involved in all of these approaches, and the decision has to be made 
considering the application and the translation from research to the final tissue engineered 
product. The other big question facing researchers is the choice between already 
differentiated cell types and stem cells, either embryonic or adult. Stem cells have the 
ability to proliferate in an undifferentiated state or, with the application of certain stimuli, 
to differentiate into one or more cell lineages. Investigators have recognized the 
tremendous potential of stem cells in regenerative medicine, and given their versatility, 
they can offer a valuable solution for engineering complex tissues. Embryonic stem cells 
are isolated from embryonic or fetal tissues, and are capable of giving rise to all types of 
tissues 28. Adult stem cells can be mainly categorized into hematopoietic and 
mesenchymal stem cells. Hematopoietic stem cells (HSC) derive from the bone marrow 
and are progenitor blood cells. Mesenchymal stem cells (MSC) can be found in a variety 
of tissues, as for example the bone marrow, the periosteum, or adipose tissue, and can 
differentiate into bone, cartilage, muscle, fat, and other tissues 29, 30. Most craniofacial 
tissues derive from mesenchymal stem cells. A recent review article by Mao et al 3 
outlines the advances in the field of craniofacial tissue engineering using stem cells. 
Once in the body, stem cells will receive signals which will govern their fate. 
These signals can be chemical or mechanical in nature, and are provided either by the 
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physiologic environment or can be incorporated in the cell delivery vehicle. The 
mechanisms by which these signals exert their effects on stem cells are not yet fully 
understood. The field of tissue engineering is greatly advanced by stem cell biology 
findings, and tissue engineering scaffolds have been used with promising results for stem 
cell delivery for various tissues. The nature of injectable materials, which allows for 
simultaneous cell and bioactive agent encapsulation, makes them particularly attractive 
for this application, and so does the ability to control these scaffolds' mechanical 
properties, which can provide the appropriate mechanobiological environment. 
Injectable hydrogel systems with or without the addition of growth factors, were 
shown to promote mesenchymal stem cell differentiation, with possible applications in 
bone and cartilage regeneration 31, 32. By controlling the scaffolds' swelling and 
mechanical characteristics, appropriate signals were transduced to the cells. Also the 
addition of a functional group to the polymer has been shown to induce cell 
differentiation, as for example a group that will enhance biomineralization, helping MSC 
tum into bone-forming cells 33. Yamada et al utilized the abundance of growth factors in 
blood platelets by delivering MSC in a platelet-rich plasma gel, observing bone formation 
and neovascularization in vivo 34. Morphogenic factors are often co-injected with cells, 
but can also be applied to the cells to pre-differentiate them in vitro prior to 
administration. An example for engineering complex tissues using the latter strategy is 
the work of Alhadlaq et al 35. Rat mesenchymal stem cells were treated for three to four 
days with either chondrogenic or osteogenic supplements and loaded in two hydrogel 
layers formed by photopolymerization. After four weeks in vivo, stratified layers of 
chondrogenesis and osteogenesis were observed. The authors concluded that this 
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approach can offer a solution for tissue engineering complex tissues using a single adult 
mesenchymal stem cell population. 
Biomaterial scaffold design criteria t 
Following the classic tissue engineering paradigm, cells are seeded on a 
biomaterial scaffold with or without the addition of chemical or mechanical stimuli. The 
scaffold provides a three-dimensional supporting environment for the cells and should 
ideally guide tissue growth. Biomaterials have been a topic of extensive research in the 
past decades, and a plethora of scaffolds for diverse tissue engineering applications has 
been developed. Having as ultimate scope the clinical translation, researchers have 
established certain criteria that have to be met for a material in order to be considered. 
Some physiologically relevant design criteria are summarized in the next paragraphs. 
These variables are crucial for the success of a material in a tissue engineering 
application and should be considered during its design. These criteria are general 
guidelines; they have to be reviewed and applied according to the intended usage. 
t The following section was included in: L. Klouda, J.D. Kretlow and A.G. Mikos, Tailored 
biomaterials for tissue engineering needs and their clinical translation, in: Translational 
Approaches in Tissue Engineering and Regenerative Medicine, J.J. Mao, G. Vunjak-Novakovic, 
A.G. Mikos and A. Atala, editors, Artech House, Boston, 2008, 325-337 
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Biocompatibility 
Biocompatibility as defined by D. Williams in 1999 is "the ability of a material to 
perform with an appropriate response in a specific application" 36. This definition 
encompasses the significant fact that the response to a material will vary according to the 
use and situation, and also that the appropriateness of the response may vary. For tissue 
engineering applications, a scaffold used as a cell substrate should not elicit any 
undesirable effects on them, and further cause any inappropriate local or systemic 
responses in the host 37. Moreover, also any potential leachable products as well as the 
degradation products in the case of a biodegradable scaffold must be biocompatible 38. 
Therefore, the synthetic and purification processes must be adapted in order to yield 
biocompatible materials and remove any potentially harmful components. 
Biodegradation 
Biodegradation is again a parameter that varies with the application. Although 
there is a general consensus that biomaterials in tissue engineering represent a temporary 
scaffold and must be thus biodegradable, the rate of degradation strongly depends on the 
desired function. A material must degrade in the body in order to provide space for new 
tissue development, however it should maintain its structural and mechanical properties 
until the newly-formed tissue is able to sustain itself. This is particularly important in the 
case of load-bearing tissues like bone. The degradation rate of a material can be tailored 
during its synthesis by incorporating chemical moieties that allow for hydrolytic scission 
of the molecules, rendering it faster degradable in the aqueous physiologic environment. 
Additionally, the molecular weight as well as the crosslinking density influence 
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degradation in the case of polymers, and so does the presence of particulates such as 
ceramics 39. 
Porosity 
A tissue engineering scaffold needs to be porous. This requirement is two-fold, 
firstly because pores allow for space that can be used for cell and tissue growth, and 
secondly as they enable nutrient and oxygen exchange as well as waste removal. A 
biomaterial fabrication process can be selected to yield porous constructs, for example 
rapid prototyping techniques 40 and electrospinning 41. Moreover, a porous structure can 
be introduced by the addition of porogens into the bulk material matrix such as micro-and 
nanopartic1es. 
Mechanical properties 
Another parameter that is strongly application-dependent is the mechanical 
properties of the biomaterial. In the cases of cardiovascular tissues or bone for example, a 
scaffold has to perform well mechanically to bear the loads in the place of the diseased or 
missing tissue, for a period until the growing tissue can do so by itself. The mechanical 
properties of the surrounding matrix can influence also cellular differentiation and tissue 
morphogenesis 42. There are several techniques used to produce mechanically strong 
materials. Starting with the materials, the initial mechanical properties as well as those 
over time can be examined for different existing materials. Also the synthetic process can 
be optimized by selecting building blocks that enhance the strength of the resulting 
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material as well as the fabrication process that can result in a crosslinked system or the 
reinforcement of a material with particles such as carbon nanotubes 43. 
Biological Properties 
A desirable feature for a scaffold is to be biointeractive and able to direct tissue 
growth. It was found that extracellular matrix (ECM) proteins containing specific 
peptide sequences possess adhesion domains recognized by cellular receptors 44. In order 
to facilitate cellular adhesion and function, those proteins or peptide sequences alone are 
coupled to a biomaterial's surface. Another approach involves the design of scaffolds that 
release growth factors in a controllable manner, stimulating cellular proliferation and 
d· = .. 11' wth 45 46 11lerentlatlOn as we as tIssue gro '. 
Handling and delivery 
Another important consideration in the design of a biomaterial for tissue 
engineering is its delivery method and the ease of handling. A scaffold can be either 
prefabricated or formed in situ. The first type usually requires a surgical procedure for its 
placement, whereas the second can be injected. Both methods have advantages and 
disadvantages and in most cases, the application will determine the appropriateness of 
each. In the case of an irregular defect for example, an injectable scaffold that will harden 
and form in vivo, filling the cavity, may be preferred. The fabrication and sterilization 
processes must be selected according to the desired product and in a manner that does not 
affect its chemical composition and properties. Furthermore, the procedure must be 
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characterized by reproducibility. In summary, according to the case and the tissue to be 
regenerated, the desired delivery method will dictate the choice of biomaterial and its 
properties will help identify the preferred fabrication procedure. 
Injectable systems in tissue engineering + 
Injectable biomaterials are widely researched and hold great promise in both the 
fields of drug delivery and tissue engineering, largely due to the minimally invasive 
nature with which they can be delivered. Injectable systems in drug delivery can be used 
both for parenteral drug delivery or localized injection to an affected site. Drug release 
kinetics can be varied via altering the character and processing of the injectable 
biomaterial matrix or depot, and the properties (size, hydrophobicity, etc.) of the drug to 
be released often have a large effect on release kinetics. For a patient, injectable delivery 
systems offer the advantage of avoiding surgical procedures and the host of potential 
complications thereof to implant the drug depot or, in the case oflong term drug delivery, 
elimination of the need for repeated doctors visits or potentially dangerous indwelling 
percutaneous lines. Thus a long term drug delivery system deliverable via a simple 
injection holds multiple benefits for patient safety and quality of life. 
• The following section was included in: L. Klouda*, J.D. Kretlow* and A.G. Mikos, Injectable 
matrices and scaffolds for drug delivery in tissue engineering, Advanced Drug Delivery Reviews, 
59 (2007), 263-273 (* equal contributors) 
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Tissue engineering is a relatively new field that seeks to regenerate human tissues 
through the use of some combination of cells, bioactive molecules such as drugs or 
growth factors, and a biomaterial support system or scaffold. The need for such 
technology is readily apparent; with the continued aging of the population, the current 
shortage of donor organ availability will likely only grow, and strategies to address the 
shortage through increased donation are fraught with medical 47-50 and ethical concerns 51-
55. The ability to regenerate damaged tissues and organs to a healthy and functional state 
using the body's own healing capabilities and without the need for long term immune 
suppression represents a near ideal solution to this growing problem. Injectable materials 
for use in tissue engineering share the same advantages as those used in drug delivery. 
Additionally, in tissue engineering applications, injectable biomaterials that form 
scaffolds in situ have the advantage of being able to take the shape of a tissue defect, 
avoiding the need for patient specific scaffold prefabrication, which is particularly useful 
in the case of irregular defects. Injectable scaffolds eliminate the need for surgical 
interventions for delivery, and the minimally invasive procedure of injection reduces 
discomfort and complications for the patient. Also problems of cell adhesion and 
bioactive molecule delivery are overcome as, under proper conditions, they can be easily 
incorporated in the solution by mixing prior to injection. 
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Thermoresponsive hydrogels § 
Hydrogels are composed of hydrophilic homopolymer or copolymer networks and 
can swell in the presence of water or physiological fluids. Chemical cross links (covalent 
bonds) or physical junctions (e.g. secondary forces, crystallite formation, chain 
entanglements) provide the hydrogels' unique swelling behavior and three-dimensional 
structure 56-58. Hydrogels have been a topic of extensive research in the past decades and 
their properties as for example their high water content and the possible control over the 
swelling kinetics make them very attractive for biomedical applications. More 
specifically, in situ forming hydrogels can provide a means for simple, "custom-made" 
therapeutics and diagnostics. A polymer solution can be prepared and allowed to gel in 
situ, after photopolymerization 59,60, chemical crosslinking 61,62, ionic crosslinking 63 or 
in response to an environmental stimulus such as temperature, pH or ionic strength of the 
surrounding medium 64,65. Hydrogels that respond to temperature change are the subject 
of this review. Their sensitivity to the thermal environment is useful as temperature is the 
sole stimulus for their gelation with no other requirement for chemical or environmental 
treatment, and can be thus produced e.g. upon injection to the body, when temperature is 
increased from ambient to physiological. 
The following section was included in: L. Klouda and A.G. Mikos, Thermoresponsive 
hydrogels in biomedical applications, European Journal of Pharmaceutics and Biopharmaceutics, 
68 (2008), 34-45 
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The phenomenon of transition from a solution to a gel is commonly referred to as 
sol-gel transition. Some hydrogels exhibit a separation from solution and solidification 
above a certain temperature. This threshold is defined as the lower critical solution 
temperature (LCST). Below the LCST, the polymers are soluble. Above the LCST, they 
become increasingly hydrophobic and insoluble, leading to gel formation. In contrast, 
hydrogels that are formed upon cooling of a polymer solution have an upper critical 
solution temperature (UCST) 65. The sol-gel transition of thermo sensitive hydrogels can 
66-68 be experimentally verified by a number of techniques such as spectroscopy 
differential scanning calorimetry (DSC) 66,67 and rheology 66. 
There are various mechanisms behind thermogelation in aqueous solutions, and 
for some polymers they are still a topic of debate. Many polymers show a decrease in 
solubility that is attributed by changes in the overall hydrophilicity of the polymer chains 
upon temperature change. When a polymer is dissolved in water, there are three types of 
interactions that take place: between polymer molecules, polymer and water and between 
water molecules. For polymers exhibiting an LCST, temperature increase results in a 
negative free energy of the system which makes water-polymer association unfavorable, 
facilitating the other two types of interactions. This negative free energy (~G) is 
attributed to the higher entropy term (~S) with respect to the increase in the enthalpy 
term (~H) in the thermodynamic relation ~G = ~H - T~S. The entropy increases due to 
water-water associations which are the governing interactions in the system. This 
phenomenon is the so-called hydrophobic effect 66,69,70. Polymer micelle packing 71 and 
coil to helix transition causing network formation 72 are examples of the conformational 
changes that take place at the critical solution temperature. All of these result in a 
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reversible physical linking of the polymer chains, and gels can therefore return to solution 
after the thermal stimulus that caused their gelation is removed. 
This chapter reviews the applications of thermosensitive hydro gels in fields of 
interest for pharmaceutical and biomedical scientists and engineers. It emphasizes mainly 
the use of hydrogels based on natural polymers, N-isopropylacrylamide (NiPAAM) 
polymers, poly( ethylene oxide )-b-poly(propylene oxide )-b-poly( ethylene oxide) (PEO-
PPO-PEO) as well as poly( ethylene glycol) (PEG)-biodegradable polyester copolymers. 
The structure of some thermoresponsive hydrogel-forming polymers is illustrated in 
Figure II-I. As there are some excellent reviews 73, 74 summarizing the literature on 
thermosensitive hydro gels published in the past years, the scope of this work is to cover 
the advances in the field from 2004 until 2006. 
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Figure II-I: Chemical formulas of polymers that form or are part of thermoresponsive 
hydrogels. 
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Figure II-I (continued): Chemical formulas of polymers that form or are part of 
thermoresponsive hydrogels. 
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Natural polymers and derivatives 
Many natural polymers have been shown to exhibit gelation upon temperature 
change. Researchers have used them alone or in combination with synthetic polymers to 
fabricate thermally responsive hydro gels with desired properties. 
1. Polysaccharides 
1.1 Cellulose derivatives 
Cellulose is a natural polysaccharide which is insoluble in water. Substitution of 
the hydroxyl groups on cellulose with more hydrophobic units as methyl or 
hydroxypropyl groups renders the originally insoluble cellulose water soluble 66 
Methylcellulose (MC) is a cellulose derivative that has been extensively investigated for 
biomedical applications. It has thermoreversible gelation properties in aqueous solutions, 
gelling at temperatures in the range of 60-80°C and turning into a solution upon cooling 
66,75. Liu et al. 76 have grafted methylcellulose with the synthetic N-isopropylacrylamide 
(NiP AAm), combining the thermogelling properties of both materials. It was possible to 
prepare fast reversibly thermogelling hydrogels by adjusting the ratios of the two 
components. They reported that a low percentage of methylcellulose decreases the LCST 
as compared to pNiP AAm, but with a high MC ratio the LCST increases. They also 
found that addition ofMC to NiPAAM polymers enhances the mechanical strength of the 
hydrogel with no syneresis. The phenomenon of syneresis occurs when a hydrogel 
shrinks and expels previously imbibed water. 
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Another interesting approach towards a thermosensitive hydrogel system based on 
methy1cellulose was recently reported by Stabenfeldt et al. 77. As it had been shown 
before 78 that methylcellulose showed low protein adsorption and cell adhesion, 
Stabenfeldt et al. functionalized methY1cellulose with the protein laminin, aiming towards 
the creation of a bioactive scaffold for neural tissue engineering. In order to facilitate 
laminin tethering, methY1cellulose was oxidized prior to functionalization. They reported 
that the laminin-functionalized oxidized methy1cellulose hydrogel promoted neuronal cell 
adhesion and showed higher cell viability rates than methyl cellulose, oxidized 
methycellulose or laminin-functionalized methy1cellulose. Moreover, the concentration 
could be adjusted so that the hydrogel exhibits a lower critical solution temperature 
slightly below physiological temperature. 
1.2 Chitosan 
Chitosan is produced with the deacetylation of chitin, which can be found in the 
outer skeleton of shrimp and insects, among others. We would like to refer the reader to 
the excellent review by Gariepy and Leroux 74 which covers the developments of 
thermo sensitive chitosan-polyol salt hydrogels until 2004. More recently, Bhattarai et al. 
79 incorporated poly(ethylene glycol) (PEG) into chitosan and were able to form a 
thermoreversible hydrogel with no additional crosslinking agents. Moreover, PEG 
grafting improved the solubility of chitosan in water, and the gelation was found to be 
possible in physiological pH values. The same group 80 evaluated the PEG-grafted 
chitosan for controlled drug release in vitro. Using albumin as a model protein, an initial 
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burst release was observed, which was followed by a steady release from the hydrogel for 
about three days. After this time, the remaining albumin could not be released from the 
hydrogel until the gel matrix was dissolved in the media. When the PEG-grafted chitosan 
was crosslinked in situ with genipin, a crosslinking agent with low cytotoxicity, quasi-
linear drug release was possible for up to 40 days; however the hydrogel lost its 
thermoreversibility at 37°C. 
Chitosan-based hydrogels have been also investigated as potential cell carriers for 
tissue engineering applications. A copolymer ofNiPAAm and water-soluble chitosan was 
tested for chondrogenic differentiation of human mesenchymal stem cells (hMSC). The 
hydrogel showed a stable gelation at 37°C and differentiation ofhMSC into chondrocytes 
was observed, both in vitro and in vivo. This hydrogel could be used for a minimally 
invasive treatment of vesicouretral reflux with an endoscopic procedure through a single 
injection 81. Dang et al. 82 modified chitosan by adding hydroxybutyl groups to its 
hydroxyl and amino reactive sites, rendering it water soluble and thermally responsive. 
The resulting hydrogel could gel within seconds after exposure to physiological 
temperature and was sufficiently strong to be handled with, as for example to measure 
mechanical properties. Upon cooling, the gel returned to liquid state. Having as an 
ultimate goal the treatment of degenerative disc disease, the hydrogel's interaction with 
hMSC and cells derived from the intervertebral disc was tested. The cells were able to 
proliferate and produce extracellular matrix when encapsulated in the hydro gels for a 
period up to two weeks. 
A chitosan-glycerophosphate salt (GP) hydrogel was recently tested for its 
potential in neural tissue engineering. This thermally responsive hydrogel, as developed 
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initially by Chenite et al. 83, has been shown to have good biocompatibility in vitro, but it 
hadn't been yet tested with nerve cells. Crompton et al. 84 compared the hydrogel to 
polylysine-functionalized chitosan-GP, with the hypothesis that the peptide polylysine 
might improve neuronal adhesion and neurite outgrowth. When neurons were grown in a 
two-dimensional culture, the functionalized hydrogel did not seem to significantly affect 
cell survival as compared to chitosan-GP, but it was observed that increasing 
concentrations of polylysine inhibited neurite outgrowth. However, when the cells were 
cultured in a three-dimensional functionalized gel, a geometry that is more representative 
of the extracellular matrix environment, in certain polylysine concentrations more cells 
were viable than on non-modified chitosan-GP. The authors concluded that polylysine-
chitosan-GP may be a good candidate for neural tissue engineering. 
1.3 Dextran 
A modified precursor of the enzymatically biodegradable dextran (Dex) was 
formed by reaction with maleic anhydride (MA) and the Dex-MA polysaccharide was 
given thermoresponsive properties by photocrosslinking it with NiP AAm. The resulting 
hydrogel was partially biodegradable and exhibited a higher LCST than pNiP AAm due to 
the hydrophilic and biodegradable nature of Dex-MA. Additionally, the carboxylic end 
groups of Dex-MA render the hydrogel pH sensitive 85. Another approach based on a 
dextran polysaccharide was reported by Huang et al 86. A dextran macromer containing 
oligolactate and 2-hydroxyethyl methacrylate units (Dex-Iactate-HEMA), which has 
hydrolytically degradable blocks, was copolymerized with NiP AAm. This hydrogel 
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showed an LCST close to that of pNiPAAm (approximately 32°C). Its swelling and 
degradation in phosphate buffered saline (PBS) were studied at 25 and 37°C. At 25°C, 
which is below the LCST, the hydrogels had disintegrated within two weeks, with the 
rate of dissolution depending on their composition. At 37°C however, the degradation 
was much slower due to increased hydrophobic effects. Interestingly, when the hydrogel 
was tested for drug delivery, it was shown that a low molecular weight drug (methylene 
blue) was released slower at 25°C than at 37°C, whereas the opposite was observed for a 
high molecular weight substance (bovine serum albumin). The authors concluded that the 
drug release profile depends on a number of factors, such as the temperature, the swelling 
and degradation characteristics of the hydrogel, as well as the interactions of the drug and 
the hydrogel macromolecules. 
1.4 Xyloglucan 
Xyloglucan is a cytocompatible polysaccharide and has exhibited thermally 
responsive behavior when more than 35% of its galactose residues are removed 87. 
Xyloglucan gels have been used as a drug delivery vehicle for various applications 74, 
however there are not many data on the rheological and morphological characteristics of 
these hydrogels. Nisbet et al. 88 have examined the gelation properties of xyloglucan 
hydrogels as well as their morphology under physiological conditions. The gelation 
process seemed to be influenced by the presence of ions in PBS as compared to deionized 
water. As to the optimum concentration, it was found that 3% (wt.) xyloglucan in 
aqueous media possess an elastic modulus that is significantly higher than other natural 
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or synthetic hydrogels. Moreover, this concentration yielded a gel that could be freeze-
dried and examined with scanning electron microscopy. The images showed a 
macroporous, interconnected, three-dimensional network. 
2. Proteins 
2.1 Gelatin 
Gelatin is another biopolymer with thermoreversible properties. At temperatures 
below 25°e, an aqueous gelatin solution solidifies due to the formation of triple helices 
and a rigid three-dimensional network. When the temperature is raised above 
approximately 30oe, the conformation changes from a helix to the more flexible coil, 
rendering the gel liquid again 72. As the opposite thermal behavior is desired for 
biomedical applications, researchers have combined gelatin with other polymers, which 
show thermal gelation close to body temperature. Gelatin has the advantage of allowing 
for easy modification on the amino acid level; moreover, it is biodegradable and 
biocompatible 89. A binary-component hydrogel composed of gelatin and monomethoxy 
poly(ethylene glycol)-poly(D,L-lactide) (mPEG-DLLA) block copolymers was 
synthesized by Yang and Kao 89. For most compositions of gelatin and mPEG-D LLA, the 
hydrogel was shown to flow at 37°e and gel at room temperature, however a 100 mg/mL 
gelatin solution underwent fast gelation at 37°e when mixed with 30% wt. mPEG-DLLA. 
Different hydrogel compositions were also examined for drug release kinetics with 
gentamycin sulfate as the model drug. At room temperature, five days or longer was 
necessary for 50% drug release, and the release lasted up to 40 days. At 37°e, gelatin-
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mPEG-DLLA showed an even slower release profile, however after one week the release 
was no longer detectable due to degradation of the hydrogel matrices. 
Ohya and Matsuda 90 have grafted gelatin with NiP AAm in an effort to produce a 
thermoresponsive extracellular matrix analogue. Aqueous solutions showed a sol-gel 
transition at physiological temperature when the weight ratio of pNiP AAm to gelatin 
chains was higher than 5.8. Smooth muscle cells were suspended in medium solutions of 
pNiPAAm/gelatin and subsequently incubated at 37°C. It was shown that a low hydrogel 
concentration (5% w/v) and a high pNiPAAm to gelatin ratio (PIG) supported the highest 
cell proliferation and extracellular matrix production. The authors suggested that this was 
due to increased hydrophobicity caused by higher pNiP AAm ratios, which would lead to 
the formation of large aggregates. As a result, a higher porosity with larger pore size 
occurs, which comprises a favorable cell environment. 
Another protein-based hydrogel was proposed by Gil et al. 91. Gelatin was 
blended with silk fibroin to yield a thermoresponsive gel, which was stabilized at 37°C by 
the presence of ~ crystals of silk fibroin. The swelling profile at temperatures below and 
above the helix-to-coil transformation of gelatin was evaluated, as well as the protein 
release from the matrices. The gel showed a higher swelling at physiological 
temperatures as compared to 20°C, but also higher mass loss due to dissolution and 
release of gelatin. 
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N-Isopropylacrylam ide-base d systems 
Hydrogels based on poly(N-isopropylacrylamide) (pNiPAAm) and its copolymers 
belong to the most intensively investigated thermoreversible systems. Recent 
developments on pNiPAAm-based hydrogels include their use for drug delivery 67,68,92, 
93, cell encapsulation and delivery 94, 95 and cell culture surfaces 96. Poly(N-
isopropylacrylamide) is non-biodegradable and exhibits a sharp phase transition, with an 
LCST at about 32°C in pure water 93,97. Below the LCST, pNiPAAm assumes a flexible, 
extended coil conformation in aqueous solutions. At the LCST, it becomes hydrophobic 
and the polymer chains seem to collapse prior to aggregation in globular structures 69, 98. 
Copolymerization of NiP AAm with a more hydrophilic monomer increases the overall 
hydrophilicity of the polymer, and the stronger polymer-water interactions lead to an 
increase in the LCST. Likewise, copolymerization with a more hydrophobic monomer 
results in a lower LCST than pNiPAAm 99. Moreover, the phase transition temperature is 
influenced by the presence of salts 100 and pH to a certain extent 97, 100. 
Coughlan and colleagues 92 evaluated the swelling and release profile of 
crosslinked pNiP AAm hydrogels as a function of the physicochemical properties of the 
loaded drugs. Dried hydrogel discs were loaded by sorption of a drug solution, the 
solvent was removed and the hydro gels were allowed to swell in a buffer solution. 
Hydrogel swelling was decreased in the presence of hydrophobic drugs and the opposite 
effect was observed for hydrophilic drugs. At temperatures above the LCST, the system 
showed contraction and deswelling, and a solubility-dependent drug pulse release was 
shown for hydrophobic drugs, whereas hydrophilic drugs showed a molecular weight-
dependent drug pulse. The authors suggested that drug properties such as solubility, size 
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and chemical nature should be considered when a thermosensitive hydrogel such as 
pNiP AAm is chosen as a delivery vehicle. 
Copolymers of NiP AAM have also been popular in attempts to yield hydrogels 
with thermal responsiveness and improved properties. The hydrogel potential of 
NiPAAM copolymers with acrylic (AA) 67, 95 and propylacrylic acid (PAA) 68 was 
examined. The thermoreversible p(NiPAAm-co-AA) hydrogel was tested as a cell and 
drug delivery vehicle. Chondrocytes, dexamethasone and ascorbate as differentiation 
factors as well as transforming growth factor ~3 (TGF-~3) were encapsulated in the 
hydrogel and were implanted subcutaneously in mice. The chondrogenic factors were 
provided in order to hinder chondrocyte de-differentiation in vivo, After 8 weeks, 
significant collagen II expression as well as proteoglycan and polysaccharide production 
was evident, indicating that the cells had preserved their phenotype. This hydrogel in 
combination with the differentiation and growth factors holds promise for cartilage tissue 
engineering 95. Liu 67 et al have synthesized p(NiPAAm-co-AA) and polymerized it with 
ethyl acrylate (EA) using the interpenetrating polymer network (lPN) technology. An 
interpenetrating polymer network is formed by hydrophilic and hydrophobic networks 
that are only physically interconnected, without any chemical bonding, so that individual 
components retain their original properties. The same group 101 had found that IPN 
structures are effective amphiphilic drug carriers. A pH dependence on the swelling ratio 
of p(NiP AAm-co-AA) as well as of interpenetrating polymer network with ethyl acrylate 
(p(NiPAAm-co-AA)/pEA IPN) was observed at 37°C. This was attributed to the presence 
of the carboxyl group on the acrylic acid. Swelling was lower on the IPNs due to the 
hydrophobic pEA. The drug release kinetics of both hydro gels were evaluated using 
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daidzein as a model drug. P(NiPAAm-co-AA) showed an initial burst release, which was 
not observed on p(pNiPAAm-co-AA)/pEA IPN. It was concluded that the pEA chains in 
the IPN structure had a favorable effect in maintaining a slower and more stable release 
profile 67. Also, copolymers of NiPAAm with propylacrylic acid (PAA) show a 
temperature and pH-sensitive behavior. Yin et al 68 synthesized copolymers by a 
reversible addition fragmentation transfer (RAFT) method, using different NiP AAm and 
P AA ratios. They showed that even small changes in pH can have a big effect on the 
LeST of the hydrogel. This feature can be useful for applications such as drug delivery, 
where physiological temperature and local pH differences can both act as stimuli, and for 
molecular switching over a desired pH range. 
An interesting approach to a combination of stimUli-responsive attributes was 
recently proposed by Xu et al. 102 in the form of a triblock copolymer hydrogel. A 
poly( (2-dimethyl amino ) ethyl methacrylate-co-2-hydroxyethyl methacrylate )-b-poly(N-
isopropylacrylamide )-b-poly( (2-dimethyl amino )ethyl methacrylate-co-2-hydroxyethyl 
methacrylate) or p(DMAEMA-co-HEMA)-b-p(NiP AAm)-b-p(DMAEMA-co-HEMA) 
copolymer was synthesized by atom transfer radical polymerizations (ATPR). The 
hydroxyl groups on HEMA allowed for chemical crosslinking with glutaraldehyde 
through acetal formation. The hydrogel showed combined characteristics of its building 
blocks: Its temperature-responsive behavior was attributed to pNiPAAm and the pH-
sensitivity to pDMAEMA. 
The Mikos group 94 has synthesized thermo gelling macromers for fabrication of a 
hydrogel for orthopedic tissue engineering applications. The aim was to yield a gel with 
better mechanical properties than most hydrophilic injectable hydro gels. This was 
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accomplished by incorporating a hydrophobic domain that provides cohesive interactions 
as well as functional groups for chemical crosslinking. A copolymer of pentaerythritol 
monostearate diacrylate (PEDAS), N-isopropylacrylamide (NiPAAm), acrylamide 
(AAm) and 2-hydroxyethyl acrylate (HEA) was synthesized. PEDAS contains a 
lipophilic side chain, and AAm and HEA can modulate hydrophilicity and add groups for 
subsequent acrylation and crosslinking. The thermal gelation is attributed to the NiP AAm 
block. Studies so far have shown that the macromers possess a thermoreversible 
behavior. Future work is directed into further development and characterization of the 
hydrogel and examination of its potential in bone regeneration. 
Another issue that has to be addressed is biodegradability. Many homo-and 
copolymers of NiPAAm are not biodegradable 103, a fact that may prove problematic for 
some biomedical engineering applications. Nakayama and colleagues 93 have prepared 
thermally responsive, biodegradable polymeric micelles for controlled drug release. A 
hydrophobic block in the micelles was used to incorporate water-insoluble drugs. By 
combining a poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) (p(NiPAAm-co-
DMAAm)) block, which has an LCST around 40°C, with poly(D,L-lactide), poly(s-
caprolactone) or poly(D,L-lactide-co-s-caprolactone), which are all biodegradable and 
hydrophobic, the group was able to fabricate polymeric micelles with controlled 
dimensions and phase transition temperatures. Below the LCST, the thermoresponsive 
block forms the outer shell of the micelle, but upon temperature increase above the 
LCST, the block becomes increasingly hydrophobic and shrinks. In the case of 
p(NiPAAm-co-DMAAm)-b-p(D,L-lactide-co-s-caprolactone) diblock copolymer, 
temperature increase above the LCST proved to facilitate drug release. 
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Polymers based on pNiP AAm have found applications in another field crucial to 
biomedical scientists: Their thermoresponsive behavior has been proven useful in cell 
culture substrates. By introducing a pNiP AAm layer on tissue culture plates, the 
hydrophilicity of the substrate can be modulated with a temperature switch. It is well 
known that most cells preferentially adhere to hydrophobic surfaces. Above its LeST 
(32°C), pNiP AAm shows a hydrophobic behavior. It represents therefore a suitable 
surface for cell attachment and proliferation at physiological temperature. By lowering 
the temperature below the LeST, the culture surface becomes hydrophilic and the cells 
automatically detach 104. This cell recovery technique is a good alternative to the 
conventional, but often damaging, enzymatic or mechanical detachment methods. 
Recently, Hatakeyama et al. 96 have been producing bioactive, thermoresponsive cell 
culture surfaces by immobilizing the cell adhesive peptide RGDS and the growth factor 
insulin on a NiPAAm-copolymer. N-Isopropylacrylamide was copolymerized with its 
analogue 2-carboxyisopropylacrylamide and the polymer was grafted onto polystyrene 
tissue culture dishes, followed by RGDS and insulin immobilization. They found that 
these factors increase cell adhesion and proliferation, reducing therefore culture time. 
When the temperature was brought to 20oe, the cells could be easily recovered as 
contiguous tissue mono layers. 
PEO/PPO-based systems 
Triblock copolymers poly( ethylene oxide )-b-poly(propylene oxide )-b-
poly(ethylene oxide) (PEO-PPO-PEO), known also as Pluronics® or Poloxamers, are 
another important group of synthetic polymers with a thermoreversible behavior in 
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aqueous solutions. By adjusting the composition, the molecular weight and the 
concentration, this reversible gelation can occur at physiological temperature and pH 105. 
The polymers owe their amphiphilic structure to the hydrophilic ethylene oxide and the 
hydrophobic propylene oxide. The gelation mechanism ofPEOIPPO block copolymers in 
aqueous solutions has been a topic of extensive investigation, and a possible explanation 
for this phenomenon could be given by the changes in micellar properties as a function of 
both concentration and temperature. Amphiphilic block copolymer molecules can self 
assemble into micelles in aqueous solutions. Above a certain concentration, termed as the 
critical micelle concentration (CMC), the polymer molecules, which were previously in 
solution, aggregate and form micelles. Members of the Pluronics® family which are used 
for drug delivery exhibit a CMC of 1 flM to 1 mM at 37°C. Moreover, the micelle 
formation has strong temperature dependence. Below a certain temperature, termed the 
critical micelle temperature (CMT), both ethylene and propylene oxide blocks are 
hydrated and poly(propylene oxide) is relatively soluble in water. With temperature 
increase, poly(propylene oxide) chains become less soluble, resulting in micelle 
formation 71. 
As Pluronics® are commercially available in a range of molecular weights, 
composition ratios and forms, it would be useful to mention the nomenclature rules for 
these copolymers. The letter in the notation stands for liquid (L), paste (P) or flakes (F), 
whereas the first two numbers are an indication for the molecular weight of the PPO 
block and the last number is the weight fraction of the PEO block. For example, the 
commonly used in biomedical applications F127 has a weight percentage of 70% PEO 
and a molecular weight ofPPO around 4000105. 
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Over the past years, these copolymers have been extensively used in applications 
such as drug and gene delivery 71, inhibition of tissue adhesion 106, 107 and bum wound 
covering 108, 109. Newer advances in gene delivery are summarized elsewhere 110. 
Pluronics® represent a bio-inert environment, imparted by the hydrophilicity and 
flexibility of PEO chains 111. Therefore, most cells do not grow on these polymers, which 
have been used as tissue adhesion barriers. However, it was shown that Pluronics® can 
be a good substrate for hematopoietic stem cells, supporting their culture and 
preservation more than conventional tissue culture dishes 112, 113. Recently, the use of 
Pluronic® F127 (synonymous to poloxamer 407) was reported for tissue engineering 
applications. This polymer has been found to have a rapid gelation at 37°C (after one-
minute incubation, 30% solution in cell culture medium) 114. F127 was evaluated as a 
scaffold for lung tissue engineering, showing promising results on tissue growth with low 
inflammatory response 115. Weinand and colleagues 114 tested a ~-tricalcium phosphate 
(~-TCP) scaffold, using a F127 hydrogel to facilitate cell delivery and distribution for an 
in vitro study aiming at bone regeneration. They reported that F127 was no longer present 
in the channels of the ~-TCP scaffold after one week in culture and seemed to have 
degraded. Bone tissue growth was only weakly induced, and the constructs showed lower 
stiffness than other hydrogel (fibrin, collagen I) composites evaluated. 
In general, Pluronic® F127 has been found to have inadequate mechanical 
integrity which makes it inappropriate for certain biomedical applications. The hydro gels 
show a low viscosity, which has as consequences poor mechanical strength, high 
permeability and limited stability with quick dissolution 116, 117. Cohn and colleagues 
proposed two new mechanisms to create copolymers based on Pluronic® F127 with 
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improved mechanical properties. In both cases they relied on the principle of a multiblock 
backbone with the addition of covalently bound repeating units. This way, the 
macromolecular structure and orientation could be controlled. The first involved the 
polymerization of F127, with hexamethylene diisocyanate as a chain extender, forming 
poly(ether-urethanes). The second relied on the covalent binding ofpoly(ethylene glycol) 
and poly(propylene glycol), which as such do not possess thermo gelling properties at 
physiological temperatures, using phosgene as a coupler and forming poly( ether-
carbonates). Both newly synthesized polymers exhibited significantly higher viscosities 
than F127 at 37°C, and the poly(ether-urethanes) displayed much slower drug release 
kinetics than the original polymer 116. The group developed the idea of thermo responsive 
PEOIPPO polymers with improved mechanical behavior further in the next years. Their 
strategies included i) introduction of end groups that would allow for in situ chemical 
crosslinking after thermal gelation, such as carbon-carbon double bonds 118, ethoxysilane 
groups 117, 119 and methacrylate groups 119 ii) synthesis of poly(ethylene oxide) and 
poly(propylene oxide) block copolymers using diacyl chloride as a coupling agent 120 iii) 
synthesis of PEOIPPO copolymers with incorporation of s-caprolactone 120, 121 or lactide 
121 oligoester segments prior to chain extension. The latter approach yielded 
biodegradable hydrogels due to hydrolytic cleavage of the ester bonds. 
The need for more stable hydrogels was identified also by Cellesi et al. 122-124 
Their approach mimicked the natural thermal gelation of alginate by relying on the 
occurrence of a physical mechanism, imparted by the thermosensitive nature of 
Pluronics®, followed by an irreversible chemical mechanism, due to covalent 
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crosslinking by the reaction of groups at the termini of the copolymer. They named their 
gelation approach "tandem process" due to the cooperative action of both mechanisms. 
Pluronic® polymers were functionalized with acrylic moieties and thiols at their 
end groups and were subsequently gelled at 37°C, where a Michael-type addition took 
place and allowed for a slower chemical curing. It was found that these polymers were 
biocompatible, and so was their gelation process, which can be performed at 
physiological temperature and pH, allowing for encapsulation of sensitive drugs and cells 
123. In order to limit steric hindrance phenomena, a similar method was followed with 
Tetronic® polymers, which are thermo sensitive tetra-armed Pluronic® analogues 124. By 
adjusting the molecular weight of the precursors and the functionalization (therefore also 
the crosslinking density), the final mechanical and transport properties of the "tandem" 
polymers can be controlled 122, 124. Moreover, the "tandem" method allows for easy 
processing of the polymers, for example into spherical beads and hollow capsules 122. 
Other synthetic polymers 
1. PEG/Biodegradable polyester copolymers 
The copolymerization of hydrophilic, biocompatible poly(ethylene glycol) (PEG) with 
biodegradable and biocompatible polyesters has yielded some interesting hydrogel 
systems. Thermoresponsive properties were given by the appropriate adjustment of the 
hydrophobic polyester block and the PEG block length. 
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In 1997, Jeong 125 and colleagues reported the synthesis of injectable 
poly( ethylene glycol)-h-poly(D,L-lactic acid-co-glycolic acid)-h-poly( ethylene glycol) 
(PEG-PLGA-PEG) triblock copolymers. These polymers were biocompatible, 
biodegradable and exhibited a sol-gel transition. The use of high molecular weight-PLGA 
combined with low molecular weight-PEG resulted in a hydrogel with quick gelation at 
physiological temperature. The combination of hydrophobic/hydrophilic units created a 
surfactant behavior of the polymers in water, facilitating thus also the solubilization of 
hydrophobic drugs. In vivo studies showed sufficient mechanical properties and integrity 
for longer than a month 126. More recently, Chen et al. 127 developed a triblock PLGA-
PEG-PLGA-based system for the controlled release of testosterone. Testosterone is 
water-insoluble and so far, its delivery systems included patches, creams, gels, injectables 
and implants 128. A slower in vitro release of testosterone was observed for copolymers 
with longer PLGA blocks, possibly due to the slower degradation of these hydrophobic 
units. The thermo sensitive polymers showed a controlled, linear release for a period of 
three months. 
Another recent approach towards a thermoresponsive system involved the 
synthesis of a multiblock copolymer with a biodegradable polyester. Alternating 
multiblock poly( ethylene glycol)/poly(L-lactic acid) (PEGIPLLA) copolymers were 
produced. It was shown that sol-to-gel transition was depending on both the total 
molecular weight (MW) and the MW of each building block. In vitro and in vivo gelation 
studies determined that a copolymer with a total MW of 6700 daltons and 600/1300 (MW 
of PEGIPLLA blocks respectively) holds potential as an injectable carrier for biomedical 
applications in terms of transition temperature and modulus at 370C 129. 
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The Mikos group has proposed the combination of methoxy poly( ethylene glycol) 
(mPEG) with poly(propylene fumarate) (PPF) and the synthesis of a mPEG-PPF-mPEG 
triblock copolymer 130. Copolymers exhibited an LCST depending on the molecular 
weight of mPEG, and it was shown that their LCST was strongly influenced by the 
presence of salts. Moreover, the presence of the fumarate double bonds on PPF can allow 
for chemical crosslinking, thus enhancing the stability of the hydrogels. Recently, this 
hydrogel was evaluated for articular cartilage tissue engineering 131. Chondrocytes were 
encapsulated in the hydrogel at 37°C and subsequently tested for their phenotypic 
characteristics. It was found that chondrocytes cultured in PEGIPPF hydro gels 
proliferated and produced significant levels of proteoglycans and collagen type II, which 
are both markers of the chondrocytic phenotype. When compared to cells cultured in 
agarose and alginate hydrogels, two materials widely studied for chondrocyte delivery, 
proliferation levels in PEGIPPF were similar, however proteoglycan and collagen 
production was lower. Supplement of the bone morphogenic protein 7 in PEGIPPF 
hydrogels was also shown to increase chondrocyte proliferation, but not proteoglycan 
synthesis. 
2. Poly( organophosphazenes) 
Current advances on poly(organophosphazenes) include their use as drug 132, 133 
and cell 134 delivery systems. Poly(organophosphazenes) grafted with mPEG and amino 
acid esters were reported as a new class of biodegradable and thermosensitive polymers 
in 1999 103. Sohn and colleagues 135 developed a correlation for the LCST of these 
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polymers as a function of their molecular structure, which comprises hydrophilic (PEG) 
and hydrophobic (amino acid esters) side groups. The polymers showed a sustained 
release profile for both hydrophobic 133 as well as hydrophilic 132 drugs for over three and 
two weeks respectively. Also their use as cell carriers holds promise, as shown recently. 
Hepatocytes cultured in poly( organophosphazene) hydrogels were able to maintain good 
viability and liver-specific activity for a period of four weeks 134. 
Conclusions 
Extensive research over the past years in biomaterials and tissue engineering has 
yielded promising results towards the regeneration of damaged or lost tissues. One 
commonly encountered problem that might benefit from this emerging strategy is 
craniofacial bone defects, for which no ideal solution exists yet. Combined progress in 
cell biology and biomaterials science has identified suitable cell sources as well as 
materials and the parameters that need to be tailored for each application. Injectable 
hydrogel systems have been used as space filling agents and for cell and bioactive 
molecule delivery. Considering the potentially sensitive nature of the cells and drugs to 
be delivered, thermoresponsive hydrogels may provide the additional advantage of a mild 
and quick gelation method in response to temperature change from ambient to 
physiological, without the use of external solidification factors. 
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CHAPTER III 
SYNTHESIS AND CHARACTERIZATION OF THERMORESPONSIVE AND 
CHEMICALLY CROSSLINKABLE, AMPHIPIDLIC POLY(N-
ISOPROPYLACRYLAMIDE)-BASED MACROMERS ~ 
Abstract 
In this study, we synthesized and characterized a series of macromers based on 
poly(N-isopropylacrylamide) that undergo thermally induced physical gelation and, 
following chemical modification, can be chemically crosslinked. Macromers with 
number average molecular weights typically ranging from 2000 - 3500 Da were 
synthesized via free radical polymerization from, in addition to poly(N-
isopropylacrylamide), pentaerythritol diacrylate monostearate, a bifunctional monomer 
containing a long hydrophobic chain, acrylamide, a hydrophilic monomer, and 
hydroxyethyl acrylate, a hydrophilic monomer used to provide hydroxyl groups for 
further chemical modification. Results indicated that the hydrophobic-hydrophilic 
balance achieved by varying the relative concentrations of comonomers used during 
; This chapter has been published as follows: M.C. Hacker, L. Klouda, B.B. Ma, J.D. Kretlow 
and Antonios G. Mikos, Synthesis and Characterization of Injectable, Thermally and Chemically 
Gelable, Amphiphilic Poly(N-isopropylacrylamide)-Based Macromers, Biomacromolecules 9, 
(2008), 1558-70 
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synthesis was an important parameter in controlling the transition temperature of the 
macromers in solution and stability of the resultant gels. Storage moduli of the 
macromers increased over four orders of magnitude once gelation occurred above the 
transition temperature. Furthermore, chemical crosslinking of these macromers resulted 
in gels with increased stability compared to uncross linked controls. These results 
demonstrate the feasibility of synthesizing poly(N-isopropylacrylamide)-based 
macromers that undergo tandem gelation and establish key criteria relating to the 
transition temperature and stability of these materials. The data suggest that these 
materials may be attractive substrates for tissue engineering and cellular delivery 
applications as the combination of mechanistically independent gelation techniques used 
in tandem may offer superior materials with regard to gelation kinetics and stability. 
Introduction 
One of the primary problems facing researchers and clinicians in the broad field 
of tissue engineering and regenerative medicine is the fabrication of biomaterial 
substrates that provide appropriate three-dimensional architecture, mechanical support, 
and the ability to deliver both cells and growth factors tailored to a specific tissue of 
interest. In situ gel formation is a concept of great interest for tissue engineers as it 
enables the delivery of a hydrogel matrix encapsulating cells and growth factors to 
defects of any shape using minimally invasive surgical techniques 136, 137. 
So far, no ideal technique toward achieving in situ gel formation exists. Various 
natural and synthetic polymers have been chemically modified with moieties for 
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chemical crosslinking, including acrylic esters, methacrylic esters, cinnamoyl esters 138, 
fumaric esters 137, and vinylsulfone 139, to yield injectable biodegradable matrices 140. In 
situ gel formation by radical polymerization of electron-poor olefins can be induced 
photochemically or thermally without harming encapsulated cells 141,142. However, only 
low concentrations of radical initiators and crosslinking agents are tolerated by 
encapsulated cells 142,143, and thus certain important parameters such as gelation kinetics, 
cross linking densities and resulting mechanical properties of the hydrogels can only be 
varied to a limited extent without compromising the cytocompatibility of the process. 
Polymeric materials that respond to a variety of environmental stimuli such as 
changes in temperature, pH, osmotic pressure, ionic strength, pressure, and electric or 
magnetic field 136, 144, 145 have become attractive materials in biotechnology and medicine 
144 and represent a viable approach to developing in situ gelling biomaterials. 
Temperature-sensitive hydrogel-forming polymers are among the most common of such 
materials and have been extensively studied as temperature-regulated drug delivery 
systems 74, 146-149 and injectable matrices for tissue engineering 56, 136, 150. While soluble 
below a characteristic temperature, solutions of these polymers undergo thermally 
induced, entropically driven phase separation above their lower critical solution 
temperature (LCST). 
Cytocompatible chemical gelation protocols typically yield firm hydrogels after 
several minutes, while thermally induced gelation of thermosensitive polymer solutions 
occurs almost instantaneously once the LCST is reached. For cell encapsulation 
applications, thermo sensitive polymers must possess an LCST below 37°C and the 
thermally aggregated polymer chains have to retain a significant amount of water. 
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Polymer classes from which certain representatives have been shown to meet these 
characteristics include copolyethers of poly( ethylene glycol) (PEG) and poly(propylene 
glycol) 15\ copolyesters of PEG and poly(1actic acid) 152 or poly(propylene fumarate) 13l, 
homo- and copolymers of poly(organophosphazenes) 153, and copolymers of poly(N-
isopropylacrylamide) (pNiPAAm) 154, 155. PNiPAAm undergoes a sharp and reversible 
phase transition at an LCST of 32°C, but when used at the physiological temperature of 
37°C, linear pNiPAAm collapses substantially and precipitates as a separate phase. 
pNiP AAm copolymers containing small amounts of hydrophilic molecules, such as 
acrylic acid, PEG or hyaluronic acid, however, demonstrated reversible gelation around 
body temperature without significant syneresis 156-158. Another method to stabilize 
pNiP AAm copolymers above the LCST is to copolymerize the monomers in the presence 
of a crosslinker to yield polymer networks 150, which in part limits the injectability of the 
materials 149. Despite this limitation, combining functional groups within a 
macromolecule such that in solution there is physical gelation in response to 
physiological temperature upon injection and radical crosslinking at a slower kinetic rate 
in situ is a concept that can yield superior materials with regard to gelation kinetics and 
ultimate mechanical properties. In addition, control over hydrogel properties might be 
improved through the combination of two mechanistically and kinetically independent 
gelation techniques. The few studies that have explored such tandem gelation concepts 
for biomedical applications have used modified pNiP AAm-based and polyether-type 
thermo gelling materials that were chemically cured after physical in situ gelation by 
Michael-type addition reactions between thiols and acrylates 123,159,160. 
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This study describes the synthesis of novel injectable pNiPAAm-based 
thermogelling macromers that are modified with olefinic moieties available for chemical 
cross linking in vivo and that contain biocompatible hydrophobic domains. This design is 
expected to yield novel water-soluble environmentally responsive amphiphiles that not 
only combine two independent gelation mechanisms but also incorporate hydrophobic 
domains for mechanical reinforcement and increased hydrophobicity of the thermo gelled 
and crosslinked hydrogel matrix. A radical polymerization strategy is proposed to 
copolymerize the thermo sensitive component N-isopropylacrylamide (NiPAAm) with 
other acrylic monomers to yield the functional amphiphiles. Pentaerythritol diacrylate 
monostearate (PEDAS), a bifunctional monomer consisting of the biocompatible 
tetrafunctional alcohol pentaerythritol esterified with two acrylic acids and stearic acid, a 
natural, metabolically resorbable fatty acid, provides the hydrophobic domain and 
NiPAAm the thermogelling properties, while acrylamide (AAm) was selected as a 
hydrophilic comonomer to adjust the transition temperature of the macromer, and 2-
hydroxyethyl acrylate (REA) was introduced to increase the number of hydroxyl groups 
available for chemical modification to yield chemically crosslinkable macromers. This 
study presents a protocol to yield water-soluble thermogelling amphiphilic macromers 
composed of PEDAS, NiP AAm, AAm, and REA. Specifically, two series of macromers, 
one consisting of poly(PEDAS-stat-NiPAAm-stat-AAm) terpolymers and the other 
poly(PEDAS-stat-NiPAAm-stat-AAm-stat-REA) copolymers, with different comonomer 
ratios were synthesized and characterized by nuclear magnetic resonance (NMR) 
spectroscopy and gel permeation chromatography (GPC). Solutions of the macromers 
were characterized for their phase transition properties by differential scanning 
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calorimetry (DSC) and oscillation rheology. Macroscopic gelation studies were 
performed to identify the thermodynamic stability of the thermogels. Candidate 
amphiphiles were (meth)acrylated to yield chemically crosslinkable thermo gelling 
macromers, which were then analyzed for chemical composition and crosslinking 
characteristics. Thermally and chemically crosslinkable macromers are presented that are 
potential building blocks for novel hydrogel systems with improved mechanical 
properties for orthopedic applications. 
Materials and Methods 
Materials 
Pentaerythritol diacrylate monostearate (PEDAS), octadecyl acrylate (ODA), N-
isopropylacrylamide (NiPAAm) , poly(NiPAAm) (pNiPAAm), acrylamide (AAm), 2-
hydroxyethylacrylate (HEA), 2,2/ -azobis(2-methylpropionitrile) (azobisisobutyronitrile, 
AlliN), acryloyl chloride (AcCI), methacryloyl chloride (MACl), anhydrous sodium 
carbonate, 4-methoxyphenol, ammonium persulfate (APS), and N,N,N',N'-
tetramethylethane-I,2-diamine (TEMED) were purchased from Sigma-Aldrich (Sigma, 
St. Louis, MO) and used as received. The solvents tetrahydrofuran (THF), diethyl ether 
and acetone were obtained from Fisher Scientific (Pittsburgh, PA) in analytical grade and 
were used as received unless stated differently. THF used during macromer 
(meth)acrylation was dried by refluxing over a potassium/sodium alloy for 3 days under 
nitrogen and distilled prior to use. 
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Methods 
Macromer synthesis. Statistical copolymers were synthesized from PEDAS, NiPAAm, 
AAm, and HEA using free radical polymerization (Figure III-I). A statistical copolymer 
is defined as a copolymer with an irregular (statistical) distribution of repeating units 161. 
Thermogelling macromers (TGMs) of various compositions were obtained by dissolving 
the acrylic monomers at corresponding molar comonomer ratios in THF at 60°C under 
nitrogen and initiating polymerization through the addition of AIBN (1.5 mol%). In a 
typical experiment, 3 g of PEDAS and corresponding amounts of comonomers were 
dissolved in 250 mL THF. The reaction was continuously stirred at 60°C over 16 - I8h 
and then refluxed for an additional 2h while the nitrogen atmosphere was maintained. 
The product was isolated by rotoevaporation and precipitation in cold diethyl ether. The 
filtrate was dried, dissolved in THF for a second time and again precipitated in diethyl 
ether. Precipitating the product in ether twice has been shown efficient to remove 
unreacted monomers and low molecular weight oligomers during method development. 
The final product was vacuum dried at ambient temperature and ground to a fine powder. 
Table III-I summarizes the different TGMs that were synthesized and characterized. 
IIro~ 
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Figure III-I: Synthetic scheme for thermogelling macromers by radical 
copolymerization (Step I). The resulting macromer is a branched statistical copolymer. 
The schematic illustration of its structure is very simplified recognizing that a PEDAS 
repeating unit can be part of two linear chains thus contributing to the branched structure 
of the macromer (A indicates possible branching sites). All copolymers in this study are 
synthesized from a comonomer ratio of a:(b+c+d) = 1 :20. Theoretically, three out of four 
indices (p,m,n,o) could equal zero in possible products. In the ideal case, the ratio 
p:m:n:o equals a:b:c:d. (Meth)acrylate moieties that enable chemical crosslinking of the 
macromer are introduced in the second reaction step. Pendant hydroxyl groups that can 
be reacted in this methacrylation step are found in the PEDAS and HEA repeating units 
of the macromer and will be converted to different degrees (s, s' ). 
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Table III-I: Compositions and molecular weight characteristics of thermogelling 
macromers 
Actual molar IH-NMR results 
Theoretical molar comonomer (based on 1 mol GPC results 
composition feed (based on 1 mol 
PEDAS) PEDAS) 
PEDAS:NiPAAm: NiP AAm:AAm:HEA NiP AAm:AAm:HEA Mn [Da] PI 
AAm:HEA (b:c:d in Figure III-I) (m:n:o in Fig. III-1) 
Effect of AAm content 
1120/-/- 20.0/-/- 20.7/-/- 2660 ±130 3.4±0.2 
1118.5/1.5/- 18.6/1.6/- 19.112.11- 2450 ±280 2.6±0.2 
1118/2/- 18.0/2.0/- 18.912.4/- 1870 ± 30 2.5±0.3 
1117/3/- 17.0/3.0/- 16.412.11- 1860 ±260 2.7±0.2 
1116/4/- 16.0/4.1/- 13.3/4.2/- 1690 ± 80 2.7±0.1 
1114/6/- 13.9/6.0/- 10.0/5.2/- 1470 ±250 6.9±2.1 
Effect of HEA content 
1116/-/4 15.9/-/4.0 17.5/-/5.8 3050 ±140 2.9±0.2 
1115.4/113.6 15.4/1.0/4.2 17.0/1.3/3.2 3810 ±260 3.0±0.3 
1115.4/2/2.6 15.3/2.012.6 17.4/1.812.0 2070 ± 90 2.7±0.1 
1115.4/2.6/2 15.4/2.7/2.2 15.0/3.112.8 2030 ±190 2.9±0.2 
1115.4/3/1.6 15.113.011.9 14.0/4.0/0.9 1930 ±120 2.9±0.4 
1115/3.5/1.5 15.2/3.5/1.5 15.8/3.1/2.0 2110 ± 60 3.7±0.6 
1114/3/3 14.0/3.0/3.0 15.2/2.0/3.4 2630 ±200 2.9±0.0 
1113.5/3.5/3 13.4/3.5/3.0 11.6/6.6/2.2 2770 ± 80 2.7±0.2 
Control 
ODA/15.4/311.6 15.4/3.111.7 15.5/5.111.8 2450 ± 80 2.1±0.0 
Macromer (meth)acrylation. Methacrylated TGMs (TGM-MA) or acrylated TGMs 
(TGM-Ac) were obtained through the conversion of TGMs with MACI or AcCI in 
anhydrous THF in the presence of anhydrous sodium carbonate as scavenger for any 
acidic byproducts. In a typical reaction, 5 g of vacuum dried TGM, 2.5 g of sodium 
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carbonate, and approximately 120 mg of 4-methoxy phenol as radical inhibitor were 
weighed into a three neck flask, which was subsequently purged with nitrogen and sealed 
against moisture. The nitrogen stream was maintained throughout the entire reaction. 
THF (75 mL) was added through a septum and the polymer was dissolved under vigorous 
stirring. Thereafter, the reaction was chilled to below -10°C using an ice-sodium chloride 
bath. As soon as the temperature dropped below -lOoC, the (meth)acrylation agent 
(MACl or AcCI) was added dropwise by means of a plastic syringe with needle through 
the septum. This addition step was controlled by the reaction temperature which was 
maintained below -lOoC at any time. Following the addition of the (meth)acrylation 
agent, the mixture was stirred for another 16 - 18 h during which the ice was allowed to 
melt and the mixture warmed up to ambient temperature. The reaction mixture was 
filtered to remove any salt. Subsequently, the polymer solution was carefully 
concentrated by rotoevaporation, diluted with acetone, and again concentrated until 
almost dry. Enough acetone was added to redissolve the polymer. The solution was 
precipitated in cold diethyl ether. This step allows also for the removal of the radical 
inhibitor 4-methoxy phenol which is soluble in diethyl ether. The (meth)acrylated TGM 
was isolated by vacuum filtration and finally dried under vacuum at ambient temperature. 
Proton nuclear magnetic resonance spectroscopy (lH-NMR). IH-NMR spectra were 
obtained using a 400 MHz spectrometer (Bruker, Switzerland). Sample materials were 
dissolved in CDCh (typical concentration: 20 mg/mL) that contained 0.05% 
tetramethylsilane (TMS) as internal shift reference. All postacquisition data processing 
was performed with the MestRe-C NMR software package (Mestrelab Research S.L., 
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Spain). The free induction decay (FID) was Fourier transformed, manually phased, 
referenced using the TMS signal, baseline corrected, and integrated. To improve signal-
to-noise, line broadening of 1.5 Hz was applied during transformation of the FID when 
meth(acrylated) TGMs were analyzed. To determine the comonomer composition of the 
macromers relative to PEDAS, the spectra were typically integrated between 0.85 and 
0.94 ppm (ll), 0.95 and 1.24 ppm (I2), 1.25 and 1.34 ppm (B), 1.35 and 2.45 ppm (I4), 
and between 3.50 and 4.50 ppm (I5) (Fig. III-2). 13, which was attributed to 28 (b in Fig. 
III-2) out of the 32 methylene protons of the stearate chain in PEDAS was set to 28. 
Consequently, ll, which represents the methyl protons in PEDAS (a in Fig. III-2), 
yielded values ranging between 2.8 and 3.4. It was found that the use of 13 instead of II 
as internal standard yielded more accurate results because 13 comprises a higher number 
of protons. The relative molar contents of the comonomers NiP AAm, AAm and HEA 
were calculated from the values obtained for 12, 14, and 15 according to the following 
equations (indices m, n, and 0 refer to Figure III-I): 
12 = 6·nm(NiPAAm) (1) 
14 = 11 + 3·nm(NiPAAm) + 3·nn(AAm) + 3·no(HEA) (2) 
15 = 8 + nm(NiPAAm) + 5'no(HEA) (3) 
Integral 12 comprises the 6 methyl protons of the N-isopropyl group ofNiPAAm 
(p in Fig. III-2) (equation 1). 15 measures the methine proton of the latter functional 
group (i in Fig. III-2), the 8 methylene protons of pentaerythrityl core in PEDAS (e,f in 
Fig. III-2) as well as the 5 protons of the hydroxyethyl residue ofHEA (I,m,h in Fig. III-
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2) (equation 3).14 summarizes the 4 methylene protons on C2 and C3 of the fatty acid in 
PEDAS (c,d in Fig. III-2), the free hydroxyl proton in PEDAS (g in Fig. III-2), the 6 
protons of the polymerized acrylic moieties of PEDAS, as well as 3 protons from each of 
the other copolymerized monomers NiPAAm, AAm, and HEA (x,y in Fig. III-2) 
(equation 2). 
b 
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Figure 111-2: IH-NMR spectra of (a) poly(PEDASl-stat-NiPAAmwstat-AAm4) and (b) 
poly(PEDASl-stat-NiPAAmwstat-HE~). The letters assigned to the peaks correspond 
to the protons at the positions labeled in the structural elements of the copolymers. II - IS 
represent the integrals used to determine macromer composition. 
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TGM conversion upon (meth)acylation was also determined relative to PEDAS. 
The integral 13 (1.25 - 1.34 ppm) was set to equal 28 protons. The signals derived from 
the olefinic protons of the acrylate (typically: 5.9 ppm, 6.2 ppm, and 6.5 ppm) or 
methacrylate groups (typically: 5.6 ppm, 6.15 ppm) were integrated individually and the 
upfield signal (5.9 ppm (TGM-Ac) or 5.6 ppm (TGM-MA» was quantified to obtain the 
degree of (meth)acrylation relative to PEDAS. The olefinic signals located further 
downfield often overlapped with the broad signal of the -NHR proton (6 - 7 ppm) of 
NiP AAm, which lead to falsely increased signal integrals. 
Gel Permeation Chromatography (GPC). Molecular weight distributions of the different 
TGMs and (meth)acrylated TGMs were determined by GPc. A GPC system consisting of 
an HPLC pump (Waters, model 510, Milford, MA), an autosampler/injector (Waters, 
model 717) and a differential refractometer (Waters, model 410) equipped with a series 
of analytical columns (Styragel® guard column 20 mm, 4.6 x 30 mm; Styragel® HR3, 5 
mm, 4.6 x 300 mm; Styragel® HRI column, 5 mm, 4.6 x 300 mm (all Waters) was used 
with degassed chloroform (HPLC grade, Sigma) as the eluent at a flow rate of 1.0 
mLimin. Samples were prepared in chloroform at a concentration of 25 mg/mL and 
filtered prior to analysis. Macromer number average molecular weight (Mn), weight 
average molecular weight (Mw), and polydispersity index (PI) were determined relative 
to polystyrene. Three samples of each material were prepared and analyzed. 
Rheological characterization. All rheological measurements were performed on a 
thermostated oscillating rheometer (Rheolyst ARI000, TA Instruments, New Castle, DE, 
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USA) equipped with a 6 cm steel cone (1 degree). TGMs were dissolved at the desired 
concentration, 10% (w/v) unless otherwise stated, in sterile minimum essential media (a. 
modification; o.-MEM) (Sigma) and kept on an orbital shaker over 24h at room 
temperature. In case the transition temperature of the macromer solution was below 25°C, 
samples were shaken in a cold room (4°C) until the polymers were dissolved. The 
dynamic viscoelastic properties of the solutions, namely the dynamic moduli, storage 
modulus (G') and loss modulus (G"), complex viscosity (111*1), and loss angle (0), were 
recorded using the TA Rheology Advantage™ software (TA Instruments) at a gap size of 
26 /!m. When an oscillatory strain with frequency 0) is applied, the complex viscosity is 
defined as: 11*= (G"/O)) - i (G'/O)). 
Gelation properties and transition temperatures. In a typical experiment, TGM 
and control samples were loaded, cooled to 5°C, pre-sheared at a rate of 1 S-1 for 1 min, 
and equilibrated for 15 min at 5°C. The viscoelastic properties of the samples were then 
recorded during a temperature sweep from 5°C to 65°C at a rate of 1°C/min at an 
observing frequency of 1 Hz and a displacement of Ixl 0-4 rad. To characterize the phase 
transition temperature of the TGM solution, different characteristic temperatures were 
determined. Upon thermogelation different rheological properties show characteristic 
changes during the temperature sweep. The initial change in viscoelastic properties is 
characterized by an increase of G' over G" resulting in a decrease of the phase angle o. 
T Ii characterizes the temperature at the first inflection point of the temperature-phase 
angle curve. During thermogel formation the viscosity of the system increased notably. 
T T] describes the location of the inflection point of the temperature-complex viscosity 
curve. 
56 
Reversibility of the thermogelation. Samples were loaded, cooled to lOoC, pre-
sheared at a rate of 1 S-1 for 1 min, and equilibrated for 5 min at lOoC. The viscoelastic 
properties of the samples were then recorded during a set of different steps with a solvent 
trap installed. To gel the samples, a temperature sweep from lOoC to 37°C was 
performed at a rate of 4°C/min with a frequency of 1 Hz and a displacement of lxl0-4 rad 
(step I). The samples were kept at 37°C for 2 min while maintaining frequency and 
displacement at 1 Hz and lxl0-4 rad, respectively (step II). For the next 2 min at 37°C the 
displacement was increased to 1.5xl0-3 rad (step III). Thereafter, the temperature setting 
was automatically changed to 15°C and a time sweep was recorded over 90 min at a 
frequency of 1 Hz and a displacement of 1.5xl0-3 rad (step IV). In a typical experiment, 
the temperature had equilibrated at 15°C after around 2.0 min into the time sweep. G' and 
111*1 were analyzed at 15°C in step I, at the end of step II and after 60' during step IV. 
Macromer crosslinking. The cone-plate setup described above including the 
solvent trap was used to compare the gelation properties of solutions from 
(meth)acrylated TGMs with and without chemical initiation. Solutions of different 
(meth)acrylated TGMs with a concentration of 10% (w/v) were prepared in a-MEM and 
loaded on the rheometer at 15°C. Before the geometry was lowered to gap size, TEMED 
and APS solution (100 mglmL in water) were added to reach final concentrations of 20 
mM each. In control samples without chemical initiation, equal amounts of TEMED and 
water were added. The samples were pre-sheared at a rate of 1 S-1 for 1 min at 15°C 
before the viscoelastic properties were recorded in a two step protocol. A temperature 
sweep from 15°C to 37°C was performed at a rate of 5°C/min with a frequency of 1 Hz 
and a displacement of lxl0-4 rad (step I). Thereafter, the thermogel properties were 
57 
monitored at 37°C over 30 min while maintaining oscillation frequency and displacement 
(step II). For samples with a transition temperature below 20°C, the temperature sweep 
(step I) was started at 10°C. For sample comparison the complex viscosities of the 
different samples were determined at 15°C during step I and at the end of step II (30' at 
Differential Scanning Calorimetry (DSC). The transition temperature of different TGM 
solutions was also determined by DSC. Solutions of different macromers (10% w/v) were 
prepared in sterile a-MEM as described for the rheology samples and 20 ilL were 
pipetted in an aluminum sample pan (TA Instruments, Newcastle, DE) and capped. 
Thermograms were recorded on a TA Instruments DSC 2920 equipped with a 
refrigerated cooling system against an empty sealed pan as reference. In a typical run, the 
oven was equilibrated at 5°C for 10 min and then heated to 80°C at a heating rate of 
5°C/min. For samples with a transition temperature below 20°C, the measurements were 
performed between -5°C and 50°C. The transition temperature (T DSC) of the TGM 
solution was determined as the "onset at inflection" of the endothermic peak in the 
thermogram using the Universal Analysis 2000 software provided with the DSC system. 
DSC has been shown to yield phase separation temperatures that are comparable to 
values obtained by optical cloud point measurements and UV turbidimetry 69, 162; 
methods that are typically used to determine the LCST of a polymer solution. All DSC 
experiments were performed in triplicate. 
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Thermogel stability. TGM solutions (10% w/v) in a-MEM were prepared as described 
above and pipetled (450 ilL) into glass vials, which were finally capped airtight. The 
vials were placed in an incubator at 37°C and analyzed after 2h and 24h. Following 
macroscopic observation of the thermo gels, any supernatant was removed carefully using 
a syringe with needle. The amount of aspirated solvent was determined gravimetrically 
on an analytical scale and recorded relative to the amount of media that could be removed 
from control vials that had been filled with 450 ilL plain a-MEM. The relative amount of 
supernatant represents a means to characterize the amount of syneresis of the 
corresponding thermogel. 
Statistics. Unless otherwise stated, all experiments were conducted in triplicate and the 
data were expressed as mean ± standard deviation (SD). Single-factor analysis of 
variance (ANOVA) in conjunction with Tukey's Post Hoc test was performed to assess 
the statistical significance (p < 0.05) within data sets. 
Results & Discussion 
Macromer design 
Statistical copolymers of different comonomer ratios were synthesized from 
PEDAS, NiP AAm, AAm, and HEA in a free radical polymerization reaction initiated by 
AIBN in THF (Figure III-I). The main design criteria behind the amphiphilic NiPAAm-
based macromers were the incorporation of a hydrophobic moiety to improve 
intermolecular cohesion and hydrogel mechanics in the long run; the introduction of 
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hydrolytically labile bonds to foster macromer biodegradability; the presence of 
thermoresponsive domains and of functional groups that can be modified to enable 
chemical crosslinking of the macromers. Hydrophobicity has been described as an 
important design criterion for polymers in bone tissue engineering 163. Hydrophobic 
domains also contribute to cell-biomaterial interactions and can improve the mechanical 
properties of a material. Lipids and fatty acids are hydrophobic building blocks that have 
become popular in biomaterial research due to their biocompatibility, metabolic 
elimination and renewability 164-166. PEDAS was selected as a hydrophobic building 
block as it contains the natural fatty acid stearic acid. Further components of PEDAS are 
the biocompatible alcohol pentaerythritol and two acrylic moieties that allow for the 
incorporation of PEDAS in copolymers synthesized by radical polymerization. The ester 
functionalities in PEDAS are potentially prone to hydrolysis. Other polymeric 
pentaerythritol esters have shown reasonable tissue compatibility and biodegradation 167. 
PEDAS, therefore, was intended to function as a hydrophobic acrylic building block that 
mediates degradability to the copolymers. NiP AAm served as a well established building 
block for thermoresponsive polymers 156. PNiPAAm is characterized by a LCST around 
32°C and is known to show extensive phase separation at higher temperatures. To form 
stable hydroge1s, NiP AAm has been copolymerized with hydrophilic comonomers or 
crosslinked 56. Since copolymerization with the hydrophobic comonomer PEDAS would 
decrease the transition temperature, AAm was selected as a non-ionic, hydrophilic acrylic 
monomer to compensate for the hydrophobic contribution of PEDAS and adjust the 
hydrophilic-hydrophobic balance of the resulting macromer. Through HEA, free 
hydroxyl groups can be introduced into the macromer that are available for chemical 
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modification. Acrylation or methacrylation of the hydroxyl group would lead to 
crosslinkable macromers in which the (meth)acrylate functionalities are connected to the 
polymer backbone via hydrolysable hydroxyethyl esters, a design that fosters 
degradability of the crosslinked hydrogels. 
Initial experiments identified TRF as a more suitable solvent for the synthesis of 
uncrosslinked low-molecular weight macromers than toluene (data not shown). The 
reaction protocol described in the "Materials and Methods" section yielded copolymers 
that remained dissolved in the reaction mixture without increasing its viscosity 
significantly. The copolymers were precipitated out in diethyl ether and a colorless water-
and chloroform-soluble powder was obtained after vacuum drying at yields around 80% -
85%. The purification protocol was verified by comparing GPC, NMR and 
cytocompatibility analysis of TGMs purified by precipitation in diethyl ether vs. TGMs 
purified by membrane dialysis (MWCO: 1000 Da). Results indicated that the removal of 
low-molecular weight side products was equally effective with both methods. Initial 
studies further identified a 1 :20 ratio of bifunctional PEDAS to the monofunctional 
acrylic comonomers to yield copolymers of reproducible molecular weight and promising 
hydrophilic-hydrophobic balance (data not shown). In order to establish the synthetic 
protocol and identify structure-property relations, terpolymers of PEDAS, NiP AAm and 
AAm were first synthesized and characterized. Since PEDAS contains a free hydroxyl 
group, such terpolymers technically already fulfill the design criteria. Copolymers that 
contain REA as a fourth comonomer were later synthesized with the objective to increase 
the number of free nucleophilic moieties for chemical modification. All copolymers are 
referred to with their theoretical comonomer composition throughout this study. 
Synthesis and structural characterization of thermogelling poly(P EDAS-stat-NiP AAm-
stat-AAm) terpolymers 
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Statistical copolymers were synthesized from PEDAS, NiP AAm and AAm with 
the content of hydrophilic AAm varying between 0% and 30% (Table III-I). 
Qualitative IH-NMR analysis of the purified polymers revealed the absence of 
any olefinic signals (5 - 7 ppm) from unreacted monomers (data not shown) and the 
presence of all characteristic signals derived from the copolymerized monomers (Fig. III-
2, trace a). Aliphatic signals derived from the stearic acid chain of PEDAS were found at 
0.9 ppm (-CH3, 3H, triplet) and around 1.3 ppm (-CH2-, 28H, broad signal). The integral 
of the signal between 1.25 and 1.34 ppm was set to 28 and used as internal reference to 
calculate comonomer composition relative to PEDAS. Further signals were derived from 
the N-isopropyl group in NiPAAm and found at 1.15 ppm (-NH-CH(CH3)2) and 4 ppm (-
NH-CH(CH3)2), and the methine and methylene groups of the polyacrylate backbone 
together with some functionalities in PEDAS between 1.4 and 2.4 ppm. The signals at 2.9 
ppm (Fig. III-2, trace a) and 2.5 ppm (trace b) were attributed to residual water. Due to 
interactions of the moisture with the macromer molecules in CDCh, the signal was found 
to vary in intensity and chemical shift dependent on macromer composition and 
concentration (data not shown). With increasing AAm content and correspondingly 
decreasing NiP AAm content (Table III -1), the relative signal intensities of the aliphatic 
signals at around 1.15 and 1.3 ppm accordingly shifted towards the signal at 1.3 ppm 
indicating the varied comonomer composition in the copolymer (Fig. III-3A). 
Quantitative analysis of the NMR spectra revealed that copolymers at the desired 
comonomer ratios could be synthesized with appropriate control (Table III-I). 
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Figure 111-3: Close-ups of IH-NMR spectra for different TGMs illustrating qualitative 
changes in signal intensities with changing comonomer ratios. (A) Poly(PEDAS l-stat-
NiPAAmC20-m)-stat-AAmm) with m = 0, 2, 4, 6 (a-d). (B) Poly(PEDASl-stat- NiPAAmC2o-
m_n)-stat-AAmm-stat-HEAn) with min = 1/3.6 (a), 2/2.6 (b), and 3/1.6 (c). 
With regard to the applicability of these macromers as injectable materials, 
control over macromer molecular weight and branching is critical, especially since 
PEDAS is a bifunctional monomer. The free radical polymerization protocol was 
optimized to allow for the synthesis of macromers that contain one to two PEDAS 
molecules and comprise the other comonomers at the feed ratio. In any case, the 
formation of branched, high molecular weight products should be avoided. Living radical 
polymerization techniques, such as group transfer polymerization (GTP) or reversible 
addition-fragmentation chain transfer (RAFT), may likely provide better control over 
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macromer composition and molecular weight, but the requirements of comonomer 
chemistry and purity (GTP) and catalyst chemistry (RAFT) are far more specific 168. 
U sing these techniques, a systematic screening of different comonomer compositions as 
presented here would involve laborious adaptation of the protocol to the different 
comonomer compositions. The versatility of a free radical polymerization protocol 
appeared advantageous for this study especially when control of macromer composition 
and weight can be achieved. 
GPC analysis of the PEDAS-NiP AAm-AAm terpolymers with AAm contents up 
to 20% revealed number average molecular weights ranging between 1690 and 2250 Da 
(Table III-I). These values correlate well with theoretical molecular weights calculated 
for macromers that consist of one to two PEDAS precursors and the corresponding 
comonomers. The observed trend of decreasing molecular weights with increasing AAm 
and correspondingly decreasing NiPAAm content correlates with the difference in 
molecular weight between NiPAAm and AAm. Polydispersity indices between 2.3 and 
2.7 were calculated. Figure III-4 shows representative chromatograms of different TGMs 
and precursors as obtained by GPC in chloroform. The polymer chromatograms were free 
of monomer signals at around 25 min, the elution time ofNiPAAm monomers (Fig. III-4, 
trace a). PEDAS yielded a broad signal for which a PI of around 2 was determined (Fig. 
III-4, trace b). The copolymer chromatograms were characterized by a broad signal with 
a significant tail (Fig. III-4, trace c-e). As a similar shape was found for a control polymer 
containing ODA, a monofunctional lipophilic monomer, instead of the bifunctional 
PEDAS (Fig. III-4, trace c), the broad distribution was not attributed to macromer 
branching but to the amphiphilic properties and resulting possible interactions with the 
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chromatographic system. Extensive branching, indicated by a high molecular weight peak 
at low retention time (Fig. III-4, trace f) was however observed for poly(PEDASI-stat-
NiP AAmwstat-AAm6), the terpolymers with the highest AAm content. Quantitative 
analysis consequently revealed a low Mn with a high PI of almost 7 (Table III-I). Further 
studies revealed that macromer molecular weight and branching increased with 
increasing reactant concentrations and decreasing initiator concentration (data not 
shown). From the above described results one can conclude that good control over 
macromer architecture can be achieved with the established synthesis protocol for 
different comonomer compositions with AAm contents of up to 20%. 
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Figure 111-4: GPC traces of (a) NiPAAm, (b) PEDAS, (c) poly(ODA1-stat-NiPAAml54-
stat-AAm3-stat-HEAI6) (control), (d) poly(PEDASI-stat-NiP AAmI5A-stat-AAm3-stat-
HEA1.6), (e) poly(PEDASI-stat-NiPAAmwstat-AAm4), and (f) poly(PEDASI-stat-
NiPAAmwstat-AAm6) (macromer that showed formation of branched networks). 
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Thermogelation properties of poly(P EDAS-stat-NiP AAm-stat-AAm) terpolymers 
The thermogelation properties of solutions of the synthesized macromers (10% 
(w/v» were analyzed by oscillation rheology. It is known that thermally induced phase 
separation is strongly affected by solution pH and ionic strength. Therefore, cell culture 
medium (a-MEM) was used as solvent during these experiments to simulate 
physiological and in vitro cell culture conditions. Figure I11-5 shows a typical rheogram 
of a TGM, here poly(PEDASI-stat-NiPAAmwstat-AAm3.5-stat-HEA15). The 
temperature dependent profiles observed for the complex moduli G' (storage modulus) 
and G" (loss modulus), the complex viscosity 1'11*1 and the phase angle 8 are typical for 
thermogelling materials 155, 169. At low temperatures, G" far exceeded G', which was 
indicated by a phase angle 8» 45°, a property characteristic of viscous liquids (Fig. III-
5). For temperatures below 25°C, the storage modulus of the displayed TGM was below 
the detection limit of the instrument. At temperatures below the phase transition, complex 
moduli and complex viscosity of the polymer solution decreased slightly with 
temperature, which is a typical behaviour of viscoelastic polymer solutions. Upon further 
heating and thermogelation (here past 26°C), G' and G" both increased drastically with 
G' finally exceeding G" (8 < 45°), which indicated the formation of a viscoelastic 
hydrogel. The complex viscosity of the system increased by almost five orders of 
magnitude during this transition. Characteristic temperatures that were determined from 
the rheograms of different TGMs for sample comparison are the temperatures at the first 
inflection point of the temperature-phase angle curve (To) and the inflection point of the 
temperature-complex viscosity curve (T'1)' While To represents the onset of phase 
transition that is associated with colloidal aggregation of the macromers and clouding of 
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the solution, T 11 depicts the temperature at which the molecules have aggregated into a 
coherent network and form a hydrogel. 
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Figure 1II-5: Representative rheogram of poly(PEDAS1-stat-NiP AAmls-stat-AAm3.S-
stat-HEA1.5) obtained during a temperature sweep between 5 and 45°C at 1 Hz. The 
complex moduli (G' and G") and the complex viscosity 111*1 are displayed on the left y-
axis, while the right y-axis refers to the loss angle (8). The locations of the characteristic 
temperatures T 8 and T 11 are indicated by arrows. 
The transition temperatures determined for poly(PEDAS l-stat-NiP AAm20) and 
the different PEDAS-NiPAAm-AAm terpolymers are summarized in Figure III-6A. The 
figure also contains the transition temperatures as obtained by DSC (T DSC) for the 
different TGM solutions (10% (w/v) in a-MEM). The characteristic temperatures 
determined for pNiP AAm are displayed in Figure III-6B, I. Almost identical transition 
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temperatures Tii (27.4 ± 1.2 0c) and T" (27.4 ± 1.3 0c) were obtained for pNiPAAm by 
rheology. DSe analysis yielded a transition temperature of 30.7 ± 0.1 °e. The 
discrepancy between the different temperatures likely has methodical reasons especially 
since T DSC is derived from a calorimetric signal and the other two temperatures are 
derived from viscoelastic parameters relevant for material application. Poly(PEDASl-
stat-NiPAAm2o) was characterized by significantly lower values for Tii (25.7 ± 0.1 0c) 
and T" (26.8 ± 0.0 0c) (Fig. III-6A). TDSC (23.5 ± 0.6 0c) confirmed the shift towards a 
lower phase transition temperature, which is caused by the hydrophobic structures in 
PEDAS. Increasing contents of the hydrophilic comonomer AAm in PEDAS-NiPAAm-
AAm terpolymers compensated for the hydrophobic effect of PEDAS and the 
characteristic temperatures increased above the values ofpNiPAAm. For poly(PEDASl-
stat-NiPAAmwstat-AAm6), the terpolymer with the highest AAm content investigated, 
transition temperatures of34.7 ± 2.4 °e (TIi), 43.5 ± 2.3 °e (T,,), and 36.6 ± 1.4 °e (TDSc) 
were measured. A similar correlation between TGM composition and the different 
transition temperatures was found. For all TGMs a difference between Tii and T" was 
observed, which typically increased with AAm content. In comparison to pure 
pNiP AAm, for which identical values for T Ii and T" were obtained, the TGMs are 
amphiphilic molecules and the formation of micellar aggregates is likely involved in the 
colloidal aggregation of the macromers during phase transition 170. Upon thermogelation 
the micelles aggregate and packing interactions increase to form dense gels. As the 
NiP AAm residues of the amphiphilic TGMs drastically change their interactions with 
solvent molecules during thermogelation, the hydrophilic-hydrophobic balance of the 
micelle-forming macromers is also altered significantly and micelle structure affected. 
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Figure 111-6: Phase transition temperatures determined from rheology (To: o , TTl: 0) and 
differential scanning calorimetry (T DSC: x ) for different TGMs. (A) Co- and terpolymers 
composed of PEDAS, NiP AAm and different contents of AAm (m = 0-6). (B) Polymeric 
controls: (I) pNiPAAm, (II) poly(PEDASl-stat-NiPAAm16-stat-HE~) and (III) 
poly(ODA1-stat-NiP AAmI5.4-stat-AAm3-stat-HEAI .6). (C) Poly(PEDAS l-stat-
NiPAAm15.4-stat-AAm(4.6_n)-stat-HEAn) with differents contents of HEA (n = 1.6, 2, 
2.6,3.6) (D) TGMs with different NiPAAm:AAm:HEA comonomer ratios, (IV) 14:3:3, 
(V) 13:4:3, (VI) 15:3.5: 1.5. 
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Complex structural changes of the TGM solution are expected during 
thermogelation that involve micelle formation, aggregation and vesicle shrinkage upon 
macromer dehydration. With this transition, T I) depicts the onset of colloidal aggregation 
and sol-gel transition, while T'1 describes the temperature at which the macromers finally 
assemble into a coherent physical network and a dense gel is formed. For hydrophobic 
monomers (systems with low phase transition temperatures), the calorimetric transition 
(T DSc) appears to correlate with the onset of phase transition T I). With increasing 
hydrophilicity of the macromers, TDsc shifts closer towards T'1 (Fig. III-6 A,C). Since the 
different transition temperatures depend on solution concentration, trends between T DSC, 
T I) and T'1 might differ at different concentrations. The relatively low T DSC observed for 
poly(PEDASI-stat-NiPAAmwstat-AAm6) is likely attributed to the extensive branching 
of this macromer (Fig. III-6A, Table III-I). 
Due to thermodynamic instability, pNiP AAm-based thermogels show 
considerable syneresis and possibly full phase separation when the temperature is 
increased above the phase transition temperature 155, 171. With regard to biomedical 
applications, it has been shown that the extent of phase separation correlates with the 
difference between transition temperature, commonly the LCST, and 37°C. In order to 
test for the thermodynamic stability of thermogels formed by the different TGMs, 
solutions (10% (w/v) were incubated at a constant temperature of 37°C and the extent of 
syneresis was determined after lh, 2h and 24h. The results from the 2h time point are 
summarized in Figure III-7. Part A depicts the gross view of the thermogels after 2h at 
37°C. The residual gel mass is summarized in part B. The solutions were prepared and 
pipetted into glass vials at ambient temperature below the transition temperature of the 
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TGM solution. In a typical experiment thermogel formation occurred approximately 10 
min after the vials were placed into the incubator. Immediately after gelation, the gel 
volume equalled the volume of the polymer solution (450 ilL). After 24h, the residual gel 
fractions of all thermogels ranged around 10 - 15%, which was assumed to correlate with 
full syneresis and phase separation (data not shown). In accordance with the literature, 
pNiPAAm solutions (Fig. III-7, sample a) show extensive syneresis and phase separation 
at 37°C. Solutions of poly(PEDASl-stat-NiPAAm2o), which gelled at a lower 
temperature than pNiPAAm, shrunk to a comparable extent after 2h (sample b). With 
increasing AAm content, improved stability was observed for PEDAS-NiPAAm-AAm 
terpolymers (sample c, d) with poly(PEDASl-stat-NiPAAmwstat-AAm4) forming stable 
thermogels at 37°C for 2h (sample d). Solutions of poly(PEDASl-stat-NiPAAmwstat-
AAm6) (Tt') = 43.5 ± 2.3 0c) did not gel at 37°C; correspondingly, no gel fraction could 
be quantified after 2h (sample e). 
These results show that amphiphilic terpolymers were synthesized with controlled 
molecular composition and structure. TGM structure, especially the hydrophobic-
hydrophilic balance, controlled the thermally induced gelation of corresponding aqueous 
macromer solutions. The thermodynamic stability of the resulting thermogels correlated 
with transition temperature. With regard to the intended chemical modification of the 
macromers, initial tests revealed that the free hydroxyl group in PEDAS (Figure III-I) 
was not sufficiently accessible for (meth)acrylation reaction possibly due to steric 
hindrance (data not shown). In order to incorporate additional hydroxyl groups, REA was 
introduced as comonomer and initially copolymerized with PEDAS and NiP AAm. HEA 
is known as a hydrophilic monomer and was therefore considered as a building block that 
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could provide chemically accessible hydroxyl groups in combination with a potential to 
balance the hydrophobicity of PEDAS and control the transition temperature of the 
macromers. Analogous to the synthesis of poly(PEDASj-stat-NiPAAmwstat-AAm4), 
poly(PEDASl-stat-NiPAAmwstat-RE~) was synthesized at the desired composition 
and molecular weight (Table III-I). Analysis of the transition temperatures revealed 
values below 25°C for To, Ttl and TDsc (Fig. III-6B, II). As a result of intra- or 
intermolecular hydrogen bond formation the hydroxyl group of REA did not fully 
interact with water and the expected hydrophilic effect of REA was diminished in 
solution. Correspondingly, extensive syneresis was observed for these thermogels (Fig. 
III-7, sample h). Consequently, copolymers ofPEDAS, NiPAAm, AAm, and REA were 
synthesized for further experiments. The molar ratio of PEDAS to NiP AAm + AAm + 
REA was maintained at 1 :20. 
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Figure 111-7: Stability of thermogels of different comonomer composition at 37°C. (A) 
Macroscopic images of thermogels after 2 h of incubation. (B) Mass fraction of 
thermogels after 2 h. Columns and error bar represent means ± standard deviation for n = 
3. Samples: (a) pNiPAAm; poly(PEDAS I -stat-NiPAAm(20_m)-Stat-AAmm) with m = 0, 3, 
4, 6 (b-e); poly(PEDASj-stat-NiPAAm(20-m-ntstat-AAmm-stat-HEAn) with min = 2/2.6 
(f), 1/3.6 (g), 0/4 (h), 3/3 (i), 3.5/3 (k), and 3.511.5 (1). 
Synthesis and characterization of thermogelling poly(P EDAS-stat-NiP AAm-stat-AAm-
stat-HEA) copolymers 
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Copolymers containing 1 mol PEDAS, 15.4 mol NiPAAm and varying ratios of 
AAm and HEA (poly(PEDAS l-stat-NiPAAml 54-stat-AAmm-stat-HEAn» were 
synthesized at the desired composition and molecular weight distribution (Table III-I, 
Fig. III-4). A trend relating molecular weight and HEA content as a result of the 
molecular weight difference of AAm and HEA was observed. IH-NMR analysis 
confirmed the presence of HEA specific protons in the copolymers (l,h,m in Fig. 1II-2, 
trace b). The intensities of these signals were found to increase relative to the methine 
signal (4.0 ppm) of the N-isopropyl group of NiPAAm with increasing comonomer 
contents of HE A (Fig. III-3B). Figure III-4 compares the molecular weight distribution of 
poly(PEDAS1-stat-NiP AAmI54-stat-AAm3-stat-HEA16) (trace d) and poly(ODA1-stat-
NiPAAmI54-stat-AAm3-stat-HEA16) (trace c). This comparison was motivated by the 
concern of network formation due to the use of the bifunctional monomer PEDAS. ODA 
is a monofunctional monomer comprising stearic alcohol and acrylic acid making the 
lipophilic component comparable to the stearic acid domain in PEDAS. The results 
illustrate that the molecular weight distributions of the different macromers do not differ 
significantly which indicates that PEDAS-containing TGMs are most likely branched but 
not networked and still contain individual macromers of controllable molecular weight 
(Mn) in the range of 2000 - 3500 Da (Fig. III-4, Table III-I). Despite its bifunctionality, 
PEDAS is considered advantageous over ODA because the lipophilic domain of PEDAS, 
stearic acid, can be metabolized following ester hydrolysis in contrast to stearic alcohol. 
Comparison of the transition temperatures of both copolymers (Fig. III-6; B, III vs. C, 
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data set on far left), revealed significantly higher values for poly(pEDASt-stat-
NiPAAmt5.4-stat-AAm3-stat-HEA1.6), which likely indicates that the hydrophilic 
pentaerythrityl core of PEDAS positively affects the hydrophobic-hydrophilic balance 
within the macromer. Within the set of poly(PEDASt-stat-NiPAAmt5.4-stat-AAmm-stat-
HEAn) copolymers, the transition temperatures follow the structure-property relations 
established in PEDAS-NiPAAm-AAm terpolymers (Fig. C). With increasing HEA and 
decreasing AAm contents, the transition temperatures decrease. T DSC again approaches T Ii 
with increasing hydrophobicity of the TGMs. In correlation with the LCSTs, the 
thermo gel stability of poly(PEDASt-stat-NiP AAmt5.4-stat-AAmm-stat-HEAn) 
copolymers at 37°C decreased with increasing nlm ratio (Fig. III-7, samples fand g). 
Thermogel stability of amphiphilic NiP AAm-based macromers 
The TGMs were designed to contain hydrophobic domains to promote disperse 
interactions among the macromers and potentially increase mechanical stability of a 
TGM-based hydroge1. With regard to the thermogelation properties, these domains 
necessitated the incorporation of hydrophilic domains to adjust transition temperature and 
thermodynamic stability of thermally gelled TGM solutions. To test for any effects of the 
resulting amphiphilic design on the stability of corresponding thermogels, rheological 
experiments investigating the reversibility of the physical gelation were performed with 
pNiPAAm as control polymer (Fig. III-8). Two TGMs, poly(PEDASt-stat-NiPAAmw 
stat-AAm3-stat-HEA3) and poly(PEDASt-stat-NiP AAmt5.4-stat-AAm2-stat-HEA2.6), 
with calorimetric transition temperatures (T DSC) surrounding the value determined for 
pNiP AAm were selected considering the structure property relation established for TGM 
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hydrogels. Comparison of pNiP AAm with the two TGMs that were characterized by 
comparable transition temperatures revealed significant differences for the gel-sol 
transition upon cooling below transition temperature. During the rheometric experiment, 
the macromers were first gelled during a controlled temperature sweep to 37°e. After an 
isothermal phase of 2 min, the shear stress was increased and maintained for another 2 
min before the temperature was set to 15°C and changes in the complex viscosity were 
monitored (Fig. III-8). All systems underwent thermogelation upon heating to 37°C 
which was associated with an increase in complex viscosity by 3-4 orders of magnitude. 
The pNiP AAm solution showed the highest complex viscosity at 5°C and after 2 min at 
37°C. This can likely be attributed to the higher molecular weight of the pNiPAAm (Mn 
of 20 - 25 kDa according to manufacturer) as compared to the TGMs. In response to the 
temperature decrease to 15°C, the pNiP AAm system de gelled almost instantly into a 
solution with a complex viscosity as at the start of the experiment. Both TGM hydro gels, 
in contrast, maintained a significantly elevated complex viscosity for 60 min at 15°C, 
while the systems became translucent once the temperature dropped below the transition 
temperature. Macroscopic observations revealed the full reversibility of the 
thermogelation for the TGM gels after 2-3 days at 20°C and below (data not shown). This 
indicates that during thermally induced gelation of amphiphilic NiPAAm-based 
macromers colloids are formed, which are stabilized by additional intermolecular forces 
than those arising from the entropically driven aggregation of pNiP AAm domains. 
pNiP AAm-based amphiphiles appear advantageous over pure pNiP AAm hydrogels when 
increased hydrogel stability is warranted and the kinetics of the gel-sol transition is of 
minor importance. 
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Figure 111-8: (A) Representative rheograms of poly(PEDASl -stat-NiPAAm14-stat-
AAm3-stat-HEA3) (TGM) and pNiP AAm during a test for reversibility of the 
thermogelation. (B) Complex viscosity 111*1 for pNiPAAM and two TGMs as determined 
at 15°C during step I, after 2 min at 37°C, and after 60' into step IV at 15°C. Transition 
temperatures as determined by DSC (T DSC) of the different polymers are assigned to the 
right y-axis. Columns and error bar represent means + standard deviation for n = 3. 
Statistically significant differences between the complex viscosities of the TGM samples 
(60 min at 15°C) as compared to the corresponding value for pNiPAAm is denoted by #. 
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TGMs with optimized composition and gelation properties 
In view of the established structure property correlations and the design objective 
to optimize the thermodynamic stability of the TGMs and to provide a sufficient number 
of hydroxyl groups available for chemical modification per macromer, TGMs with high 
AAm and HEA contents and reduced NiP AAm comonomer contents were synthesized 
and analyzed (Table III-I). Poly(PEDASI-stat-NiPAAmwstat-AAm3-stat-HEA3) could 
be synthesized at the desired composition and molecular weight. The NMR analysis of 
poly(PEDASI-stat-NiP AAm13.S-stat-AAm3.5-stat-HEA3) revealed overly high AAm 
contents and low NiPAAm contents, a phenomenon also observed for poly(pEDASI-stat-
NiP AAmwstat-AAm6). These findings are attributed to likely colloid formation of these 
strongly amphiphilic macromers in the NMR solvent CDCh and shielding of PEDAS and 
NiPAAm protons. Increased branching was observed for poly(pEDASI-stat-NiPAAmw 
stat-AAm3.5-stat-HEA1.5), which was designed to contain half of the HEA compared to 
poly(PEDASI-stat-NiPAAmwstat-AAm3-stat-HEA3) and keep the molar AAm 
comonomer content below 4 (relative to PEDAS). Poly(PEDASI-stat-NiPAAmwstat-
AAm3-stat-HEA3) solutions were characterized by a T"I] of 33.7 ± 0.2 °C more than 5°C 
above the T"I] determined for pNiPAAm (Fig. 111-6C, I). The stability of thermogels 
formed from this TGM were also significantly increased (Fig. 111-7, sample i). A further 
increase in AAm content resulted in a TGM (poly(PEDASI-stat-NiPAAm13.s-stat-
AAm3.5-stat-HEA3» that yielded even more stable thermogels (Fig. 111-7, sample k). The 
chemical characteristics of the macromers, however, were less definite (Table 111-1), 
which explains the disperse results obtained for T&, T"I] and Tnsc (Fig. 111-6D, V). Another 
well balanced TGM was synthesized with poly(PEDASI-stat-NiPAAmw stat-AAm3.5-
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stat-HEA15), which was characterized by To and Tll comparable to poly(PEDAS1-stat-
NiPAAmwstat-AAm3-stat-HEA3) but a significantly increased TDSC (35.6 ± 0.5 DC) 
(Fig. III-6C, VI) and formed thermogels of appropriate stability (Fig. III-7, sample 1). In 
view of their favorable thermogelation properties, poly(PEDASI-stat-NiPAAmwstat-
AAm3-stat-HEA3) and poly(PEDAS1-stat-NiP AAmwstat-AAm3.5-stat-HEA15) were 
chemically modified to yield chemically crosslinkable TGMs (Figure III-I, step II). 
Synthesis and structural characterization of chemically cross likable TGMs 
With the objective to introduce chemically crosslinkable domains into the TGMs 
to yield macromers that can be gelled both physically and chemically, TGMs were 
reacted with AcCl or MACl. Anhydrous sodium carbonate was used to scavenge any 
acidic by-products during the reaction and upon termination any salt was removed by 
filtration 172. Triethylamine, which is a commonly used base to catalyze such 
(meth)acrylation reactions, could not be effectively removed from the reaction products 
due to the lack of a suitable extraction solvent that would precipitate the amphiphilic 
macromers. As described for the hydroxyl group methacrylation of other molecules 173, 
the molar excess of the acrylation or methacrylation agent, AcCl or MACl, controlled the 
extent of hydroxyl group conversion (Table III-2, Fig. III-9). Figure III-9 shows 
representative IH_NMR traces of poly(PEDASI-stat-NiPAAmwstat-AAm3-stat-HEA3) 
as well as two acrylated and one methacrylated derivative. Characteristic changes of the 
proton signal indicate successful (meth)acrylation of the TGM. Upon (meth)acrylation, 
characteristic olefinic proton signals appear between 5.6 and 6.6 ppm representing three 
(TGM-Ac) or two (TGM-MA) olefinic protons per (meth)acrylic ester. In addition, a 
79 
downfield shift of the methylene protons in a-position to the newly formed (meth)acrylic 
ester was observed (signal at 4.3 ppm). A signal at 1.9 - 2.0 ppm representing the methyl 
group of the methacrylate ester group was found in the spectrum of TGM-MA. The 
conversion was calculated relative to the PEDAS molecules per TGM and an increased 
conversion was found with higher feeds of (meth)acryloyl chloride. Poly(PEDASt-stat-
NiPAAmwstat-AAm3-stat-HEA3), the TGM with the higher HEA content per 
macromer, showed a higher conversion relative to PEDAS. A maximum of 1.25 acrylic 
groups per macromer subunit identified by one PEDAS block was achieved with an 
acryloyl chloride excess of 2.5 (relative to the theoretical number of hydroxyl groups per 
macromer subunit). This means that 1.25 out of the 4 theoretical hydroxyl groups per 
macromer subunit (3 in HEA and one in PEDAS) were acrylated. Additional experiments 
revealed that the hydroxyl group of PEDAS was not accessible for (meth)acrylation 
under the applied conditions (data not shown). 
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Figure 111-9: Close up (1.5 - 7 ppm) of IH-NMR spectra obtained for (a) poly(PEDAS1-
stat-NiPAAmwstat-AAm3-stat-HEA3 (TGM) and (b-d) (meth)acrylated poly(PEDAS1-
stat-NiP AAmwstat-AAm3-stat-HEA3 at different molar excesses of (meth)acryloyl 
chloride: (b) TGM-Ac (0.75x), (c) TGM-Ac (2.5x), and (d) TGM-MA (2.5x). Proton 
signals derived from the (meth)acrylate groups are indicated by arrows. 
Due to the lower reactivity of methacryloyl chloride, a likely consequence of 
steric limitations, a lower conversion was found for the methacrylated TGMs as 
compared to the acrylation products at corresponding molar feeds of the reactive 
chlorides (Table III-2). The transition temperatures of the (meth)acrylated macromers, 
here T DSC, were found to decrease with the extent of (meth)acrylation. As hydrophilic 
hydroxyl functionalities are turned into considerably less hydrophilic (meth)acrylic 
esters, the hydrophilic-hydrophobic balance of the macromer was changed towards 
increased hydrophobicity and the phase transition temperature decreased. A stronger 
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effect of macromer derivatization on transition temperature was found for TGM-MA, 
which is explained by the stronger hydrophobicity of the methacrylic ester as compared 
to an acrylic ester. 
Table 111-2: Methacrylated (TGM-MA) or acrylated (TGM-Ac) macromers synthesized 
from two different TGMs at increasing molar ratios of the (meth)acrylation reagents 
(XCI) methacryloyl chloride or acryloyl chloride, respectively. Conversion of TGM 
hydroxyl groups into (meth)acrylate esters as determined by IH-NMR per PEDAS 
molecule (nOlefin/npEDAS) and corresponding transition temperature of a 100/0 (w/v) 
macromer solution as determined by DSC (n = 3). 
TGM 1: 14:3:3 1: 15:3.5: 1.5 
(PEDAS :NiP AAm:AAm:HEA) 
Modification Reagent feed IH-NMR TDSC laC] IH-NMR T DSC laC] 
nXCI/nOH nOleftn/n PEDAS (nMAlAc/nPEDAS) 
Unmodified nla nla 33.1 ± 0.4 nla 35.6 ± 0.5 
Methacrylation 1.25 0.55 13.6±1.1 0.19 24.1 ± 0.6 
2.5 1.12 13.8 ± 0.5 0.57 15.2 ± 0.9 
Acrylation 0.75 0.27 25.1 ± 0.6 0.15 31.2 ± 0.2 
1.25 1.01 22.3 ± 1.2 0.64 24.6 ± 0.3 
2.5 1.25 19.6 ± 0.7 0.98 20.8 ± 0.9 
Gelation properties of chemically crosslinkable TGMs 
Results of rheological experiments performed with solutions of the 
(meth)acrylated TGMs (10% (w/v)) with and without the presence of the thermal initiator 
system APS/TEMED (25mM each) are summarized in Figure III-10. 
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Figure 111-10: Rheological characterization of solutions of different (meth)acrylated 
TGMs with (APS/TEMED) and without (H20/TEMED) chemical initiation. (A) 
Representative rheograms. (B) and (C) show the complex viscosity 111*1 at 15°C and after 
30' at 37°C for two macromers with various modifications. # denotes statistical 
significance between initiated and non-initiated samples after 30 min at 37°C. 
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Redox initiator system and concentration have been shown suitable and 
sufficiently biocompatible for direct cell encapsulation with in situ crosslinked hydrogels 
31, 142. All (meth)acrylated TGMs except acrylated (Ac 2.5x) poly(PEDAS1-stat-
NiP AAmwstat-AAm3-stat-HEA3) showed thermogelation during the initial temperature 
sweep to 37°C, which was associated with a significant increase in complex viscosity for 
samples with (APSITEMED) and without (H20ITEMED) chemical initiation (Fig. III-
10A,B). Acrylated (2.5x) poly(PEDAS 1-stat-NiP AAmwstat-AAm3-stat-HEA3)' which 
showed the highest degree of acrylation, had likely partially crosslinked during 
preparation of rheological samples. The high complex viscosity values determined for 
this sample at the beginning of the rheological experiment confirmed this assumption. 
For the other samples, low complex viscosities below 0.1 Paes were determined for the 
solutions at 15°C and no significant differences were found between the APS containing 
samples and the control samples (H20ITEMED) at 15°C (Fig. III-lOB,C). At 37°C, 
higher complex viscosity values were typically determined for initiated samples 
(APSITEMED) compared to the non-initiated controls (Fig. III-lOA). During the 
subsequent time sweep at 37°C, the complex viscosity was monitored for 30 min at 37°C. 
While the APS/TEMED groups typically maintained the values for complex viscosity 
during this time, decreasing complex viscosity values due to the thermodynamic 
instability of the physical gels were recorded for the H20ITEMED groups (Fig. III-lOA). 
This result indicates thermally initiated crosslinking of the (meth)acrylated TGMs in the 
presence of APSITEMED during the temperature sweep within a few minutes. Based on 
these findings, that show that physical and chemical crosslinking occurred almost 
simultaneously, the tested initiator concentration appears high. If slower crosslinking 
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kinetics are desired to achieve successive thermogelation and chemical crosslinking, a 
lower initiator concentration would be recommended. Comparison of the complex 
viscosities after 30 min at 37°C revealed a significant difference between the crosslinked 
macromers and the physically gelled systems. The viscosities determined for the highly 
acrylated poly(PEDAS1-stat-NiP AAmwstat-AAm3.5-stat-HEA1.5) were comparable to 
those achieved for poly(PEDAS1-stat-NiPAAmwstat-AAm3-stat-HEA3) acrylated using 
a low AcCI feed (0.75x). For this polymer higher acrylation rates could be achieved with 
AcCI feeds of 1.25x and 2.5x (Table III-2), but the viscosity of gels crosslinked from 
these macromers was decreased likely due to extensive phase separation of these 
hydrophobic macromers at 37°C (Fig. III-lOB). In general, high viscosities were reached 
by crosslinking the methacrylated macromers but their low transition temperatures 
significantly impair polymer processing with regard to biomedical applications. 
Macroscopically, the APS/TEMED systems remained as a coherent hydrogel film on the 
geometry upon disassembly of the rheometer, while the non-initiated samples resembled 
a highly viscous liquid (data not shown). The crosslinking density and (meth)acrylate 
conversion of the crosslinked hydrogels could be determined by total hydrolysis of the 
gels and subsequent chromatographic analysis 174. For all experiments, macromer 
solutions with a concentration of 10% (w/v) have been used. This concentration is 
comparably low with regard to other injectable hydro gels based on synthetic polymers 
such as poly(ethylene glycol), which typically range from 20 - 25% 31, 175, 176. The use of 
macromer concentrations higher than 10% is expected to yield TGM hydro gels with 
increased crosslinking densities. 
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Conclusions 
Amphiphilic TOMs with controlled polymer architecture and low molecular 
weight (~2 - 3.5 kDa) were synthesized from PEDAS, NiPAAm, AAm, and REA at 
different compositions and selected macromers were subsequently (meth)acrylated to 
yield chemically crosslinkable thermo gelling materials for biomedical applications. 
Structure-property correlations for non-modified TOMs were established and the 
hydrophilic-hydrophobic balance was characterized as an important design criterion to 
adjust the gelation temperature of TOM solutions and thermodynamic stability of the 
resulting thermogels. The amphiphilic design was shown to support intermolecular 
interactions, a property which could improve the mechanical stability of crosslinked 
TOM-based gels. (Meth)acrylated TOMs were synthesized and the combination of 
thermogelation and thermally induced chemical crosslinking was shown to improve 
hydrogel stability. The experiments further suggest that degree of acrylation and 
hydrophilic-hydrophobic balance of the macromers have to be well-adjusted to yield 
hydrogels of optimal stability. The synthesis of chemically crosslinkable, thermogelling, 
and potentially biodegradable macromers was realized and promising macromers for the 
design of injectable drug and/or cell delivery systems with improved properties and 
stability are presented. 
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CHAPTER IV 
CYTOCOMPATIBILITY EVALUATION OF THE MACROMERS J,.. 
Abstract 
The cytocompatibility of amphiphilic, thermoresponsive and chemically 
crosslinkable macromers was examined in vitro. Macromers synthesized from 
pentaerythritol diacrylate monostearate, N-isopropylacrylamide, acrylamide and 
hydroxyethyl acrylate in different molar ratios and with varying molecular weights and 
lower critical solution temperatures were evaluated for cytocompatibility with rat 
fibroblasts. Cell viabilities of over 60% for all and over 80% for most formulations were 
observed after 24-h incubation with macromers with molecular weights in the range of 
approximately 1500 to 3000 Da. The chemical modification of the macromers with a 
(meth)acrylate group was shown to have a time- and dose-dependent effect on cell 
viability. Uncrosslinked macromers with lower degrees of (meth)acrylation allowed for 
cell viability of over 60% for up to 6 h. (Meth)acrylated macromers with lower critical 
solution temperature (LCST) closer to physiological temperature allowed for higher cell 
viabilities as opposed to those with lower LCST. The data suggest that when the 
(meth)acrylated macromers are assembled into a physical gel, their cytotoxicity is 
).. This chapter has been published as follows: L. Klouda, M.C. Hacker, J.D. Kretlow and A.G. 
Mikos, Cytocompatibility evaluation of amphiphilic, thermally responsive and chemically 
crosslinkable macromers for in situ forming hydrogels, Biomaterials 30 (2009), 4558-4566 
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diminished. After gel phase separation, cytotoxicity increased. This study gives 
information on the parameters that enable viable cell encapsulation for in situ forming 
hydrogel systems. 
Introduction 
Injectable, in situ forming materials represent an attractive option for cellular 
delivery in tissue engineering. Hydrogels in particular are excellent extracellular matrix 
equivalents due to their highly hydrated nature 65 and can be delivered in liquid form and 
then solidify in situ. It is highly important that the solidification takes place in a clinically 
relevant time frame so that the material is localized at the point of interest. The 
solidification mechanism should be selected as not to cause necrosis to surrounding tissue 
by excessive heat formation and to be tolerated by encapsulated cells and/or any 
potentially sensitive molecules that are encapsulated for delivery. Moreover, fast 
solidification allows for homogeneous cell dispersion within the hydrogel matrix 137,177-
179. Thermally responsive hydrogels, materials that solidify upon temperature change, 
form in situ in a mild and fast manner, but they often possess insufficient mechanical 
properties and stability 148. To circumvent this problem, thermogelling polymers have 
been modified by the addition of reactive groups that allow for covalent cross linking. 
These polymers exhibit physical gelation triggered by temperature increase, followed by 
an irreversible chemical crosslinking after a Michael-type addition 124, 159, 160 or a 
photo initiated polymerization reaction 180. 
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Our group has recently proposed a type of thermally responsive, chemically 
crosslinkable macromer for the fabrication of in situ forming hydrogels based on N-
isopropylacrylamide 181. These macromers employ a hydrophobic core molecule that 
increases cohesive interactions of polymeric chains, augmenting the mechanical stability 
of the resulting hydrogel. The addition of a methacrylate or acrylate group enables 
chemical crosslinking with the use of a biocompatible, water-soluble thermal initiator 
system. The macromers are designed to exhibit a rapid thermal gelation at temperatures 
slightly below physiological temperature, followed by a slower chemical crosslinking in 
situ. The advantage of this approach is that fast solidification is achieved in a mild 
process through thermal gelation, with the subsequent slow chemical crosslinking not 
requiring high amounts of initiator. The rate of the chemical crosslinking reaction is 
dependent on the amount of initiator used, and it has been shown that thermal initiator 
systems are less cytocompatible above a certain concentration 142,143,182. 
The macromers are synthesized from pentaerythritol diacrylate monostearate, a 
bifunctional monomer containing a natural fatty acid as hydrophobic chain, N-
isopropylacrylamide, which provides thermoresponsive properties, acrylamide, a 
hydrophilic monomer, and hydroxyethyl acrylate, a hydrophilic monomer which provides 
hydroxyl groups for further chemical modification 181. The lower critical solution 
temperature (LeST) of macromer solutions and the resultant gel stability are shown to be 
a function of the comonomer ratios in the composition and the amphiphilicity of the 
macromers. As a further step, the modification of the macromers with the addition of a 
(meth)acrylate group allows for covalent crosslinking of gels with higher stability as 
compared to physically gelled, uncrosslinked controls. 
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The scope of this study is to evaluate the in vitro cytocompatibility of this type of 
macromer. Specifically, properties of unmodified macromers such as the molecular 
weight, the composition and the transition temperature are assessed for their effect on 
cytocompatibility. After chemical modification, (meth)acrylated macromers are 
evaluated to determine the optimal variables for viable cell delivery. The degree of 
modification, the concentration and the effects of acrylation versus methacrylation on cell 
viability are examined. Furthermore, cell viability is examined at intervals over 24 h in 
order to determine the length of exposure to (meth)acrylated macromers tolerable by 
cells. 
Materials and Methods 
Unmodified thermogelling macromers 
Amphiphilic, water-soluble thermogelling macromers (TGMs) were synthesized 
from pentaerythritol monostearate diacrylate (PEDAS), N-isopropylacrylamide 
(NiPAAm) and varying contents of acrylamide (AAm) and 2-hydroxyethyl acrylate 
(HEA) via a free radical polymerization reaction as previously described 181. The 
macromers were subsequently purified by precipitation in diethyl ether and were 
characterized by gel permeation chromatography (GPC), proton nuclear magnetic 
resonance spectroscopy CH-NMR), rheology and differential scanning calorimetry 
(DSC) 181. The structure of the TGMs is illustrated in Figure IV-I. Table IV-l 
summarizes the composition of the macromers evaluated in the study, denoted by their 
molar feed composition, and their respective properties. The number-average molecular 
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weights (Mn) and polydispersity indices (PI) were obtained by GPC for n=3. The lower 
critical solution temperature (T 11) had been previously determined rheologically as the 
inflection point of the temperature-complex viscosity curve (n=3). 
A 
'-J- -o 
o 
B ~~ 
o 
Figure IV-1: Structure of thermogelling macromers (A) before and (B) after 
modification with the addition of a (meth)acrylate group. The asterisk indicates possible 
branching sites. The indices m,n,o could equal zero in some formulations. The sum of the 
modified (z) and unmodified (x) hydroxyl groups equals the initial hydroxyl group 
number prior to (meth)acrylation (x+z=o). 
91 
Table IV-1: Molecular composition, molecular weight characteristics and transition 
temperature of unmodified thermogelling macromers a 
Molecular weight group 
Molar Composition Mn [Da] PI 
PEDASlNiP AAm/AAmlHEA 
1115.4/2.6/2 1750±370 3.4±0.6 31.6±0.3 
1115.4/2.6/2 2300±140 2.9±0.3 32.7±0.8 
1115.4/2.6/2 2440±420 3.0±0.8 32.6±0.2 
1/15.4/2.6/2 2830±170 3.6±0.5 31.5±1.2 
Composition group 
Molar Composition Acrylic Monomer Ratios Mn [Da] PI T,d°C] 
PEDASlNiP AAm/AAmIHEA 
(%HEA/%AAm) 
1116/0/4 20/0 3050±140 2.9±0.2 23.2±0.1 
1115.411/3.6 18/5 3810±260 3.0±0.3 26.5±0.1 
1115.4/2.6/2 10/13 1750±370 3.4±0.6 31.6±0.3 
1114/3/3 15/15 2700±120 2.7±0.1 33.7±0.2 
1116/4/0 0/20 1700±80 2.7±0.1 38.7±3.0 
LCSTgroup 
Molar Composition Mn [Da] PI T .. [0C] 
PEDASlNiP AAm/AAmIHEA 
1120/0/0 2560±250 2.7±0.1 27.2±0.2 
1118.5/1.5/0 2450±280 2.6±0.2 30.6±0.4 
1116/4/0 1700±80 2.7±0.1 38.7±3.0 
1116/4/0 1370±100 b 2.9±0.1 b 40.8±1.4 
1114/6/0 1470±250 6.9±2.1 43.5±2.3 
a Molecular composition describes the molar feed ratio of monomers as used for polymerization. 
Molecular weight characteristics were obtained by gel permeation chromatography. The 
transition temperature TTl was determined from rheological measurements of 10% (w/v) macromer 
solutions as the inflection point of the temperature-complex viscosity curve. Values represent 
means ± standard deviation for a sample size of n=3. b The average and range for this formulation 
were determined for n=2. Table is adapted from 181 with permission. 
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Cell culture 
A rat fibroblast cell line (ATCC, CRL-1764) was cultured on T-75 flasks using 
Dulbecco's modified Eagle medium (DMEM; Gibco Life, Grand Island, NY) 
supplemented with 10% (v/v) fetal bovine serum (FBS; Cambrex BioScience, 
Walkersville, MD) and 1% (v/v) antibiotics containing penicillin, streptomycin and 
amphotericin (Gibco Life). Cells were cultured in a humidified incubator at 37°C and 
5% C02. Cells of passage numbers 7-9 were used in this study. 
Cytocompatibility assays of unmodified thermogelling macromers 
Leachables assay 
Solutions of thermogelling macromers were prepared at a 10% (w/v) 
concentration in cell culture media (DMEM, supplemented with antibiotics) without the 
addition of serum. The solutions were left on a shaker table overnight to dissolve. In the 
case of macromer solutions with LCST below room temperature, the solutions were left 
to dissolve at a temperature of 4°C. After dissolution, macromer solutions were incubated 
at 37°C for 24 h. During this time interval, the solutions first gel and subsequently phase-
separate and collapse. After 24 h in the incubator, the supernatant of the macromer 
solutions was aspirated, sterile-filtered through a Nalgene 0.2 ~m filter (Nalge, 
Rochester, NY) and diluted 10 times in cell culture media. Cells were seeded on a 96-
well plate at a density of 28,300 cells/cm2 using a working volume of 100 ~L cell 
suspension per well. The cells were incubated for 24 hours to achieve 80-90% confluence 
and were then exposed to 1 00 ~L of the solution supernatant. Two experimental groups 
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were used, one without and one with 10-fold dilution (n=5). Following 24 h of 
incubation, the macromer-conditioned media were removed, and the cells were rinsed 
three times with phosphate-buffered saline (PBS, Gibco), followed by the addition of 
calcein AM and ethidium homodimer-l in 2 ~M and 4 ~M concentrations in PBS, 
respectively (LivelDead viability/cytoxicity kit, Molecular Probes, Eugene, OR). The 
cells were incubated with the LivelDead reagents for 30 min in the dark at room 
temperature. Cell viability was quantified using a fluorescence plate reader (Biotek 
Instrument FLx800, Winooski, VT) equipped with filter sets of 485/528 nm 
(excitation/emission) for calcein AM (live cells) and 528/620 nm (excitation/emission) 
for EthD-l (dead cells). Untreated cells that were cultured with primary media only 
served as the positive (live) control, whereas cells exposed to 70% ethanol for 15 min 
served as the negative (dead) control. The fluorescence of the cell populations was 
recorded and the fractions of live and dead cells were calculated relatively to the controls 
as previously described 142. Following quantification, images of the cells were obtained 
with a fluorescence microscope (LSM 510 META, Carl Zeiss, Germany). 
Direct contact assay 
The macromers were vacuum-dried and sterilized under UV irradiation for 3 h. 
Macromer solutions were prepared in 10% (w/v) concentration in DMEM without FBS as 
described above. Cells were seeded on 48-well plates at a seeding density of28,300 cellsl 
cm2 with a working volume of 500 ~L cell suspension per well. After 24-h incubation, 
the media were aspirated and 150 ~L of macro mer solution was added to the cells (n=4-
5). This quantity was calculated so that after gelation, a thin gel film would form above 
the cells. After 30-minute incubation at 37°C to ensure gel formation, 300 ~L DMEM 
94 
without FBS was carefully added on top of the gel and the cells were incubated with the 
macromers for 24 h. Following this incubation period, the gel pellet was carefully 
removed with tweezers at room temperature, and cells were rinsed three times with PBS 
before adding the LivelDead reagents and evaluating cell viability as described above. 
Modified (acrylated and methacrylated) thermogelling macromers 
In order to add chemically crosslinkable domains, the purified macromers were 
modified with the addition of an acrylate or methacrylate group through a reaction 
between the hydroxyl group of 2-hydroxyethyl acrylate (HEA) and (meth)acryloyl 
chloride. The hydroxyl group on PEDAS was not modified during this reaction. The 
reaction, purification and characterization processes were performed as previously 
described by Hacker et al. 181. The structure of modified macromers can be seen in Figure 
IV -1. Macromers with varying acrylate or methacrylate group contents were synthesized 
by feeding different volumes of acryloyl chloride or methacryloyl chloride respectively. 
Due to the lower reactivity of methacryloyl chloride, different hydroxyl conversions were 
observed in comparison to formulations that were supplied with an equivalent amount of 
acryloyl chloride. Table IV -2 denotes the composition of the modified TGMs and the 
conversion of the hydroxyls to (meth)acrylate groups as determined by I H-NMR. The 
thermal transition temperatures are also included in Table IV -2, as the substitution of the 
hydroxyl group of HEA by the more hydrophobic (meth)acrylate moieties has an effect 
on the lower critical solution temperature of these macromers. LeST was previously 
obtained by differential scanning calorimetry for n=3. 
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Table IV-2: Acrylated and methacrylated thermo gelling macromers with varying degrees 
of modification and their transition temperatures C 
Molar Composition: PEDASINiPAAm/AAmlHEA = 1115/3.5/1.5 
Modification % of bydroxyls modified TDsc 
[0C] 
No modification 0 35.6 ± 0.5 
Acrylation 8 31.2 ± 0.2 
Acrylation 32 24.6 ± 0.3 
Acrylation 49 20.8 ± 0.9 
Methacrylation 10 24.1 ± 0.6 
Methacrylation 29 15.2 ± 0.9 
C The degree of hydroxyl group conversion was determined by IH_NMR. The transition 
temperature T DSC was obtained by differential scanning calorimetry (DSC) for 10% (w/v) 
macromer solutions. Values represent means ± standard deviation for a sample size ofn=3. Table 
is adapted from 181 with permission. 
Cytocompatibility of modified (acrylated and methacrylated) thermogelling macromers 
The macromers were vacuum-dried and sterilized under UV irradiation for 3 h. 
Macromer solutions were prepared in 10, 1 and 0.1 % (w/v) concentrations in DMEM 
without FBS as described above, which will be denoted throughout the text also as 100, 
10 and 1 mg/mL respectively. Cells were seeded on 96-well plates at a seeding density of 
28,300 cells/cm2• After 24-h incubation, the media were aspirated. For the 1 and 0.1% 
solutions, 100 J.lL of macromer solution was added to the cells. These concentrations 
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showed minimal gel formation at 37°C and therefore the addition of media for nutrient 
supply was not required. For the 10% solutions, 40 ~L of macro mer solution was applied, 
followed by 30-min incubation at 37°C to ensure gel formation, and 60 ~L DMEM 
without FBS was carefully added on top of the gel. For all groups, a sample size of five 
was used (n=5). Cell viability was evaluated after 2, 6 and 24-hour incubation using the 
LivelDead assay as described above. 
Osmolality measurements 
The osmolality of the solutions was measured with an Osmette automatic 
osmometer (Precision Systems, Natick, MA). In order to create a standard curve for cell 
viability versus osmolality of solution, the osmolalities of dextran (average molecular 
weight 68.8 kDa, Sigma, St. Louis, MO) solutions in concentrations from 0 to 30% (w/v) 
in DMEM were measured. Cells were then incubated with dextran solutions in that 
concentration range for 24 h, and their viability was recorded. Dextran was chosen 
because it is a known biocompatible polysaccharide and thus in case any toxic effects 
were observed, they would be due to changes in osmolality of the solution and not 
molecular composition. 
The osmolality of the 10% (w/v) macromer solutions as used in the study was 
measured. Moreover, the osmolality of the supernatant solutions was measured. The 
supernatant was obtained after incubating the macromer solutions for 24 h at 37°C and 
following gel phase separation in order to simulate the properties of the solutions to 
which cells are exposed during the direct contact assay. 
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Statistical analysis 
Statistical analysis of the data was perfonned with a single-factor analysis of 
variance (ANOVA) with a 95% confidence interval (p<0.05). In the case of statistically 
significant differences, Tukey's post hoc test was conducted. Data are expressed as mean 
± standard deviation. 
Results 
Effect of molecular weight on unmodified macromer cytocompatibility 
Viability of over 80% was observed for cells incubated with the supernatant of 
hydrogels composed of macromers with number-average weights ranging from 1750 to 
2830 Da and polydispersity indices from 2.9 to 3.6 (Figure IV -2A). In this experimental 
group, no statistically significant differences were found between undiluted and 10-fold 
diluted samples. For the direct contact assay, viabilities of above 80% were found for the 
lower molecular weight groups (Figure IV -2B). The higher molecular weight group 
showed cell viability of 69±3 %. 
Effect of composition on unmodified macromer cytocompatibility 
Cells incubated with hydrogel supernatant showed high viabilities (above 75%) 
for all but one fonnulation, with a decrease in live cells with increasing acrylamide 
content in the composition (Figure IV -3A). The fonnulation with the highest acrylamide 
content in the composition (20%) and no 2-hydroxyethyl acrylate showed lower viability 
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values of 55±2%. No statistically significant difference was noted between undiluted and 
10-fold diluted supernatant. When cells were exposed to the thermogelling macromers in 
a direct contact assay, cell survival was above 800/0 (Figure IV -3B). 
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Figure IV-2: Cell viability after 24-h incubation with macromers of different number-
average molecular weights and polydispersity indices (PI). A) Leachables assay: 
incubation with hydrogel supernatant B) Direct contact assay: incubation with hydrogel. 
Error bars represent standard deviation; n= 3-5. 
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Figure IV-3: Cell viability after 24-h incubation with macromers of different molecular 
ratios of REA and AAm. A) Leachables assay and B) Direct contact assay. Error bars 
represent standard deviation; n= 3-5. Characters on experimental groups indicate 
statistically significant differences when groups are not marked with the same letter 
(p<O.05). For clarity purposes, in figure (A) differences are marked for undiluted group 
only. 
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Effect of LeST on unmodified macromer cytocompatibility 
Among the formulations tested, lower cell viability was observed for the 
formulations with transition temperatures of 38.7 and 40.8 °C, both in the leachables 
(55±2% and 61±5% respectively) as well as in the direct contact assay (8l±19% and 
60±22%) (Figure IV -4). Macromer solutions with lower or higher transition temperatures 
than the aforementioned showed viabilities of 70% or more for their leachable 
components and the direct contact assay. Characteristic fluorescence microscopy images 
of the cells after incubation with these macromers can be seen in Figure IV -5. High 
densities of live cells (stained green) with morphology similar to the positive control 
were observed for most formulations, and no obvious damage to cells that were in direct 
contact with the hydrogel was noted. The composition with an LCST of 40.8 °C 
(molecular composition PEDASjNiP AAmj6AAm4) showed an increased number of dead 
cells (stained red). 
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Figure IV -4: Cell viability after 24-h incubation with macromers of different transition 
temperatures (TTJ). A) Leachables assay: incubation with hydrogel supernatant B) Direct 
contact assay: incubation with hydrogel. Error bars represent standard deviation; n= 5. 
Experimental groups denoted by different letters show statistically significant differences 
(p<0.05). For clarity purposes, in figure (A) differences are marked for undiluted group 
only. 
102 
Figure IV-S: Fluorescence microscopy images of fibroblasts after 24-h exposure to 
hydrogel leachables or in direct contact with hydrogel and treatment with LivelDead 
reagent. (A) positive control, (B) negative control, (C) treatment with a formulation 
composed of PEDAS1NiPAAm2o in leachables assay (C) and direct contact (D), 
treatment with a formulation composed of PEDASINiPAAm16AAm4 in polymer-
conditioned media (E) and direct contact (F). Scale bars indicate 100 !-lm. 
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Effect of macromer solution osmolality on cytocompatibility 
Cell viability showed a decreasing trend after 24-h incubation with increasing 
osmolalities of dextran solutions in various concentrations; differences, however, were 
not statistically significant (Figure IV -6). For a solution osmolality of 451 mOsm/kg, cell 
viability was 85±7%. Thermogelling macromer solutions in 1% (w/v) concentration in 
cell culture media showed similar osmolalities to that of DMEM (330 mOsm/kg). 
Solutions of 10% (w/v) concentration had osmolalities on the order of 406-462 
mOsm/kg. The supernatant of gels after 24-h incubation at 37°C and full phase 
separation showed even lower values (340-408 mOsm/kg). 
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Figure IV-6: Osmolality of dextran solutions of different concentrations and cell 
viability values after 24-h incubation with these solutions. Differences in 
cytocompatibility are not statistically significant (p<0.05). 
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Cytocompatibility of (meth)acrylated thermogelling macromers 
Effect of macromer concentration 
At the 2 h time interval, most formulations had similar cell viabilities in 1, 10 and 
100 mg/mL concentrations or showed trends of decreasing viability (Figure IV -7). A 
formulation with a 32% degree of acrylation showed values of 0.95±0.09, 0.71±0.08 and 
0.68±0.10 at 1, 10 and 100 mg/mL respectively. A formulation with a 49% acrylation had 
cell viabilities of 1.23±0.06, 0.99±0.05 and 0.12±0.01 at the above concentrations. The 
effect of concentration was even more pronounced with decreasing trends in viability at 
the 6- and 24-h intervals. At 24 h, the cell viabilities for the 32% acrylated formulation 
decreased from 0.75±0.02 at the 1 mg/mL concentration to 0.16±0.05 at 100 mg/mL. 
Effect of time 
In addition to the aforementioned results, the effect of incubation time on cell 
viability can be seen in Figure IV -8 for a concentration of 100 mg/mL. An unmodified 
composition showed a statistically significant decrease in viability at 6 h. The fraction of 
live cells at 24 h was 0.61±0.05, which did not change from the viability at 6 h. For all 
acrylated formulations, a statistically significant decrease in viability was observed after 
24 h. At 6 h, the compositions with lower degrees of acrylation showed cell viabilities of 
60% and higher. A composition with low methacrylation also showed a statistically 
significant decrease in cytocompatibility at 24 h, whereas the macromers with higher 
methacrylation exhibited high toxicity as soon as 6 h after incubation. 
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Figure IV-7: Cell viability after (A) 2-h, (B) 6-h and (C) 24-h incubation with various 
concentrations of (meth)acrylated macromers with a theoretical composition ofPEDAS 1-
NiPAAmls-AAm3.S-HEA1.5. Error bars represent standard deviation for n=3-S. 
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Figure IV-8: Cell viability over time after exposure to 100 mg/mL solutions of (A) 
acrylated and (B) methacrylated macromers, with an unmodified composition as a 
control. Error bars represent standard deviation for n=3-S. Statistically significant 
differences over time within one composition group are marked with an asterisk (p<O.OS). 
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Effect of modification 
The macromers were rendered less cytocompatible with increasing degrees of 
modification. Figure IV -9 depicts cell viability after 24-h incubation with 100 mg/mL 
macromer solutions. Unmodified macromers showed a viability of 6l±5%, which was 
very similar for macromers with 8% acrylation. For macromers with higher acrylation 
degrees of 32% and 49%, only 16±6% and 2±1 % of the cells respectively were viable 
after 24 h. Methacrylation seemed to be less tolerable by the cells from these results. 
After 24-h incubation, cell viability was only 3± 1 % for both formulations, which had 
methacrylation degrees of 10% and 29%, respectively. 
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Figure IV-9: Cell viability after 24-h incubation with 100 mg/mL solutions of acrylated 
and methacrylated macromers with different degrees of modification. Modification is 
expressed as the fraction of hydroxyl moieties substituted by (meth)acrylate groups. Error 
bars represent standard deviation for n=3-S. 
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Discussion 
The effects of molecular weight, monomer ratios in the composition and solution 
thermal transition temperature were the parameters investigated for their effect on 
macromer cytocompatibility. A second set of studies examines the cytocompatibility of 
the macromers after the addition of a reactive (meth)acrylate group over time and for 
different compositions and concentrations. Although these macromers can be physically 
gelled and chemically crosslinked, all experiments were performed with the non-
crosslinked macromers to evaluate toxicity of the reactive groups and macromer 
composition, mainly hydrophilic-hydrophobic balance. 
Cytocompatibility of unmodified thermogelling macromers 
Macromer molecular weight is a factor that influences the compatibility of 
hydrogels with cells. Low-molecular weight oligomers are often associated with toxicity 
issues in hydrogels 65. Generally, hydrogels for cell encapsulation are fabricated with 
macromers of molecular weights above 3000 Da 183, as they otherwise may enter the cell. 
No adverse effects of thermogelling macromers with the same composition but various 
molecular weights, ranging from 1750 to 2830 Da, were observed on cell viability. Cell 
viability was over 80% for most formulations, both in the leachables as well as in the 
direct contact assay. 
As for the macromer composition, it had been shown 181 that increasing 
acrylamide contents correlates with higher transition temperatures of the macromer 
solutions (Table IV -1). Therefore, whether the decreasing cytocompatibility observed 
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with increasing acrylamide in the formulation was an effect of LCST rather than 
composition had to be evaluated. Macromers with transition temperatures higher than the 
incubation temperature stay in solution or show minimal gel formation as opposed to 
those with transition temperatures close to physiological temperature which gel rapidly at 
37°C. The experimental data showed a decrease in cell viability for the macromer 
solutions with transition temperatures close to physiological. Interestingly, a macromer 
solution with a transition temperature of 43.5 °C, which did not gel after 24-h incubation 
at 37°C, allowed for cell viability of over 70%, whereas solutions with transition 
temperatures significantly lower than physiological temperature showed similar cell 
survival values. The differences in the relative amphiphilicity may explain these 
observations. The lower critical phase separation phenomenon is imparted by 
hydrophobic interactions between macromolecular chains 184. For macromers with an 
LCST below the incubation temperature of 37°C, associations between polymer chains 
were more pronounced, leading to gel formation. On the other hand, an increase in the 
hydrophilicity of the macromers facilitated polymer-water interactions, not allowing gel 
formation at this temperature. This hydrophilic structure, as suggested by the viability 
data, caused minimal interactions with the cells. The macromers with transition 
temperatures around physiological temperature exhibited such a hydrophilic/hydrophobic 
balance at 37°C that might have caused increasing interactions with the cell membrane 
and could explain the lower cell viability values observed. 
Another possible source of toxicity evaluated, solution osmolality, does not seem 
to be a contributing factor in these studies. Cells would be first exposed to the macromer 
solution until the gelation takes place and later to the supernatant solution after gel 
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syneresis. Even though high osmotic stress has been shown to suppress growth 185 and 
induce apoptosis 186 in mammalian cells, the osmolality of solutions was within the range 
tolerable by cells as suggested the dextran osmolality-cell viability curve (Figure IV -6). 
This is in accordance with the observations of Zhu et al.187, where viable density of eRO 
cells showed an 8% decrease for a solution osmolality of 460-500 mOsm/kg. 
Cytocompatibility of modified thermogelling macromers 
Some of the macromer solutions were too viscous for sterilization by filtration. 
Therefore, the macromers were dried in a vacuum oven and sterilized under UV 
irradiation for 3 h. The presence of the olefinic protons was confirmed by IR-NMR, 
indicating that after UV irradiation the structure of the (meth)acrylated macromers was 
preserved (data not shown). The macromers selected for (meth)acrylation were chosen 
based on their amphiphilic character and lower critical solution properties, and their 
molecular composition prior to modification was found to be cytocompatible. The 
parameters tested in this study were concentration, time, degree of modification and 
modification type (acrylation or methacrylation) on their effect on cytocompatibility. It is 
valuable to obtain correlations between cell viability, concentration and chemical 
structure of the macromers as a function of time if the hydrogel is used for cell 
encapsulation, as cells will be in direct contact with the macromer chains until the 
crosslinking of the hydrogel is completed 143. 
Exposure to (meth)acrylated macromers was shown to have a dose-dependent 
effect on cell viability (Figure IV -7). This effect was more pronounced with higher 
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modification and after longer exposure. The cytotoxicity of hydrogel-forming macromers 
is often reported in concentrations of up to 1 mg/mL in cell culture media 188, 189. We 
have opted to evaluate higher concentrations relevant for hydrogel fabrication. In this 
study, when the direct contact assay was performed, cell culture medium was added on 
top of the hydrogel layer after its solidification. In the course of the 24-h incubation, the 
hydrogel was phase-separated, which means that the addition of medium diluted down 
the supernatant solution. This step was however required to ensure nutrient delivery to 
the cells. Solutions of lower concentrations did not show significant gel formation, and 
no additional media were added. The cytotoxicity of the macromers showed also a time-
dependent behavior (Figure IV -8). Acrylated macromers all showed statistically 
significant higher cytotoxicity at the 24 h time interval compared to 2 and 6-h exposure. 
The same correlation was observed for the methacrylated macromers with lower 
modification. Macromers with a higher degree of methacrylation showed significantly 
higher toxicity already after 6-h incubation compared to 2 h. This study seems to be a 
good indicator for determining the kinetics of the crosslinking reaction by establishing 
the tolerable time of exposure of cells to the (meth)acrylated macromers. It represents the 
worst-case scenario, since within the time frame examined, chains would have already 
started to crosslink with the addition of an initiator system. After crosslinking is 
completed, the detrimental effects of the (meth)acrylate end groups should be eliminated. 
The presence of reactive end groups, such as the (meth)acrylate groups, contributes to the 
toxicity of materials. Increasing degrees of modification drastically reduce cell viability, 
as can be seen in Figure IV -9. 
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To the best of our knowledge, there are only a few studies that investigate the 
cytocompatibility of (meth)acrylated, uncrosslinked macromers. Crosslinking molecules 
such as poly(ethylene glycol) diacrylate (PEG-DA-575 Da) 143 and hydrophobic 
propylene fumarate diacrylate 190 were found to be very toxic on cells, whereas higher 
molecular weight macromers such as dextran derivatized with methacrylate- and 
hydroxyethyl methacrylate groups 191 and PEG-DA (molecular weight 3.4 kDa) 143 
showed more cytocompatible results. Many studies have been carried out to elucidate the 
cytotoxic effects of acrylic and methacrylic monomers. In general, acrylic monomers 
have been reported to be more toxic than their methacrylic analogues 192, 193. Some 
researchers suggested that toxicity correlates with monomer lipophilicity, and that 
cytotoxic effects of (meth)acrylates are exerted through reacting with and disrupting the 
lipid bilayer in cell membranes 194, 195. Other researchers identified a mechanism 
involving the covalent binding of electrophilic reactive (meth)acrylates to cellular targets 
such as thiol groups on proteins through a Michael-type reaction 196, 197. In the present 
case, we found acrylated macromers to be more cytotoxic than methacrylated ones after 
2-h incubation, but after 24 hours, this phenomenon seemed to have reversed. Figure IV-
10 shows the fraction of live cells at 2 and 24 hours as a function of transition 
temperature of the macromer solutions. Our previous studies 181 showed that the hydrogel 
stability at 37°C is proportional to the LCST of the macromer solutions, and hydrogels 
fabricated of macromers with low LCST tend to phase-separate and precipitate faster. 
This offers an explanation for the higher toxicity observed for methacrylates as compared 
to acrylates with the same degree of modification after 24-h incubation. At 2 hours, the 
gels are still stable, but the precipitation over the 24-h time interval happens sooner for 
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macromers with lower transition temperatures, as in the case of methacrylates. This effect 
prolongs the period in which non-gelled, (meth)acrylated, reactive macromer chains 
interact directly with structures of the cells, such as membranes, as opposed to chains 
that are fully assembled into a gel, thus enhancing their toxic action over 24 hours. The 
results suggest that when (meth)acrylates form a gel, their cytotoxic effects are 
diminished. Macromer toxicity seems to be associated with their soluble form, or in this 
specific case, precipitated, and not when the macromolecular chains are assembled in a 
physical network. 
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Figure IV-lO: Cell viability after 2 and 24-h incubation with 100 mglmL solutions of 
acrylated and methacrylated macromers as a function of their thermal transition 
temperature. Error bars represent standard deviation for n=3-5. 
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Conclusions 
This study demonstrated the good cytocompatibility properties of thermally 
responsive, chemically crosslinkable macromers. It was found that unmodified 
macromers with number-average molecular weights in the range of approximately 1500 
to 3000 Da with varying molecular compositions allowed for high cell viability over a 
24-h time interval. The chemical modification with an acrylate or methacrylate group 
enables the chemical crosslinking of the macromers. We investigated the effect of the 
(meth)acrylate derivatization on the toxicity of uncrosslinked macromers and determined 
that a 6-h time frame for crosslinking completion would allow for viable cell 
encapsulation. Increased degrees of modification were shown to decrease the thermal 
transition temperature as well as the cytocompatibility of the macromers. Formulations 
with the parameters established in this study will be used towards the fabrication of 
injectable, thermoresponsive, in situ forming hydrogel systems for cell and drug delivery. 
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CHAPTER V 
HYDROGEL FABRICATION, CHARACTERIZATION AND MESENCHYMAL 
STEM CELL ENCAPSULATION ~ 
Abstract 
Hydrogels that solidify in response to a dual, physical and chemical, mechanism 
upon temperature increase were fabricated and characterized. The hydrogels were based 
on N-isopropylacrylamide, which renders them thermoresponsive, and contained 
covalently crosslinkable moieties in the macromers. The effects of the macromer end 
group, namely acrylate or methacrylate, and the fabrication conditions were investigated 
on the degradative and swelling properties of the hydrogels. The hydrogels exhibited 
higher swelling below their lower critical solution temperature (LCST). When immersed 
in cell culture media at physiological temperature, which was above their LCST, 
hydro gels showed constant swelling and no degradation over eight weeks, with 
methacrylated hydrogels having higher swelling than their acrylated analogs. In addition, 
hydro gels immersed in cell culture media under the same conditions showed lower 
swelling as compared to phosphate buffered saline. The interplay between chemical 
crosslinking and thermally induced phase separation affected the swelling characteristics 
~ This chapter was submitted for publication to Acta Biomaterialia as: L. Klouda, K.R. Perkins, 
B.M. Watson, M.e. Hacker, S.J. Bryant, R.M. Raphael, F.K. Kasper and A.G. Mikos, 
Thermoresponsive, in situ crosslinkable hydrogels based on N-isopropylacrylamide: Fabrication, 
characterization and mesenchymal stem cell encapsulation. 
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of hydro gels in different media. Mesenchymal stem cells encapsulated in the hydro gels in 
vitro were viable over three weeks and markers of osteogenic differentiation were 
detected when the cells were cultured with osteogenic supplements. Hydrogel 
mineralization in the absence of cells was observed in cell culture medium with the 
addition of fetal bovine serum and p-glycerol phosphate. The results suggest that these 
hydrogels may be suitable as carriers for cell delivery in tissue engineering. 
Introduction 
Thermally responsive hydrogels have attracted much research interest over the 
past years for their use in biomedical applications 73, 74, 148. They have been reported in 
drug delivery 198,199, cell sheet tissue engineering 200, biosensors 201, myocardial injection 
therapy 202 and cell delivery 155,180,203. Thermoresponsive systems use temperature as a 
stimulus to allow for solidification and changes in swelling. This is beneficial for the 
above mentioned functions, as the temperature change from ambient to physiological can 
be employed. Advantages of thermo responsive hydrogels include a fast gelation once the 
transition temperature is reached, and a mild solidification process without the need for a 
chemical initiator system. Many natural and synthetic polymers exhibit 
thermoresponsive hydrogel characteristics, and among those, polymers based on poly(N-
isopropylacrylamide) (pNiPAAm) belong to some of the most widely investigated 
systems. The homopolymer pNiPAAm has a transition temperature around 32°C, which 
can be tuned when copolymerized with more hydrophilic or hydrophobic monomers 69 
and allows for a transition temperature that can be close to physiological. A problem 
117 
associated with linear pNiPAAm is the extensive collapse of the gel at 37°C. One 
strategy to improve the stability and mechanical properties of pNiP AAm -based hydro gels 
is the modification of the polymer with functional groups that enable covalent 
crosslinking. Systems that gel with temperature increase to physiological and can form 
chemical cross links upon a Michael-addition reaction have been recently proposed 159,160, 
204,205 
Our group has previously reported the synthesis and characterization of 
macromers for the fabrication of hydrogels that can form in situ with two independent, 
physical and chemical, solidification mechanisms 181. The thermoresponsive properties 
of the macromers are imparted by N-isopropylacrylamide, and additional comonomers 
include pentaerythritol diacrylate monostearate, acrylamide and hydroxyethyl acrylate. 
The latter monomer contains hydroxyl groups that can be modified towards acrylate or 
methacrylate moieties. These moieties can be covalently crosslinked with the addition of 
a water-soluble, thermal free-radical initiator system. Increased stability and higher 
viscosity values could be achieved when the hydrogels were physically and chemically 
gelled as opposed to only thermally gelled controls. The in vitro cytocompatibility of the 
macromers has been previously evaluated with favorable results. Parameters, such as 
crosslinking time, that allow for high viability of encapsulated cells during hydrogel 
formation have been established 206. 
The objective of the present study is the fabrication and characterization of 
thermally responsive and chemically crosslinkable hydrogels that form upon temperature 
increase to physiological. The ultimate goal of this work is the application of hydrogels 
for cell delivery in craniofacial bone tissue engineering. The potential of these hydrogels 
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towards this aim in terms of hydrogel properties, cell encapsulation and mineralization 
are investigated. More specifically, we examine the effect of macromer end group 
(acrylate or methacrylate) on the swelling and degradation of the hydrogels. The resulting 
effects of these properties on encapsulated mesenchymal stem cell viability and 
osteogenic differentiation are evaluated. 
Materials and Methods 
Macromer synthesis and characterization 
Thermally gelling macromers were synthesized from pentaerythritol diacrylate 
monostearate (PEDAS), N-isopropylacrylamide (NiPAAm), acrylamide (AAm) and 2-
hydroxyethyl acrylate (REA) in a 1:14:3:3 molar ratio via free-radical polymerization 
reaction as previously described 181. Subsequently, the free hydroxyls of the REA were 
modified with an acrylate or methacrylate group through a reaction with acryloyl or 
methacryloyl chloride, respectively, and characterization followed with established 
methods 181. Formulations that contained 1.3 acrylate or methacrylate groups per chain as 
determined by lR-NMR were used for these studies unless otherwise noted. 
Hydrogel fabrication 
Methacrylated macromer solutions were prepared in phosphate buffered saline 
(PBS, pR=7.4, Gibco Life, Grand Island, NY) in a concentration of 10% (w/v). 
Ammonium persulfate (APS) and N,N,N',N'-tetramethylethylenediamine (TEMED) 
(Sigma-Aldrich, St. Louis, MO) were used as free-radical initiators for the chemical 
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crosslinking of the macromers. Stock solutions of the initiator system in double distilled 
(dd) water were added to the macromer solution in different concentrations resulting in 
final APSffEMED concentrations of 10, 15 and 20 mM. The mixture was gently agitated 
and quickly pipeted into Teflon molds (6 mm in diameter, 3 mm in height). The 
hydrogels were then formed at 37°C inside a cell culture incubator over 10, 20 or 30 min. 
After fabrication, hydrogels were blotted dry, weighed (Wf) and placed in dd water at 
37°C for one day. Gels were removed from the water, carefully blotted and the wet mass 
was obtained (Ws). The hydrogels were dried overnight in a lyophilizer and weighed 
(Wd). Sol fraction is calculated as (Wf - Wd)/ Wf. Swelling ratio is calculated as (Ws -
Wd)/Wd. 
Hydrogel swelling below and above the LeST 
Hydrogels were fabricated using APSffEMED in a 20 mM concentration and 30-
min incubation at 37°C. Hydrogels were weighed after fabrication, swollen in dd water at 
4°C for 20h, blotted and weighed. Subsequently, they were immersed in dd water at 37°C 
for 20h. The wet mass was obtained after careful blotting and gels were finally dried and 
weighed. Swelling ratio was calculated as outlined above. 
Hydrogel degradation and swelling in cell culture medium and PBS 
Hydrogel samples were prepared as described below for cell encapsulation but 
with the addition of PBS instead of cell suspension. The gels were immersed in complete 
osteogenic media or PBS in an incubator at 37°C over 8 weeks. Samples were removed at 
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Ih, I, 7, 14, 21, 28 and 56d and sol fraction and swelling ratio were calculated. 
Additionally, samples immersed in media were prepared and saved as controls for the 
biochemical assays as follows below. 
Rat mesenchymal stem cell (MSC) isolation and preculture 
Cells were harvested from the marrow of the femora and tibiae of male 6-8 week 
old Fischer 344 rats (Charles River Laboratories, Wilmington, MA) as previously 
described 207. The protocol followed in these studies was approved by the Rice University 
Institutional Animal Care and Use Committee. The cells were cultured in minimum 
essential medium Eagle-alpha modification (Sigma) supplemented with 10% v/v fetal 
bovine serum (FBS, Cambrex BioScience, Charles City, IA), 10mM ~-glycerol-2-
phosphate, 50 Ilg/mL ascorbic acid, 50 Ilg/mL gentamicin, 100 Ilg/mL ampicillin and 
1.25 Ilg/mL fungizone (Sigma). The medium was changed after 24h to remove non-
adherent cells and every 2-3 days thereafter until confluence was reached. 
Cell encapsulation and culture 
Vacuum-dried macromers were sterilized with UV irradiation for 3h 206. 10% w/v 
solutions were prepared in sterile PBS and stock solutions of APS and TEMED in dd 
water were sterile-filtered. Complete osteogenic medium was prepared as the medium 
used for MSC preculture but with the addition of 10 nM dexamethasone, an osteogenic 
supplement. Prior to encapsulation, cells were counted in a hemocytometer with trypan 
blue to confirm cell viability. Macromer solutions were mixed with APS and TEMED 
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(final concentration 20 mM) on ice. Subsequently, cells were added in a final 
concentration of 10 million cells/mL, the mixture was gently shaken and pipeted into 
sterile Teflon molds. After 30min in an incubator, the gels were transferred to l2-well 
plates and 2.5 mL complete osteogenic medium was added. The medium was changed 
after lh to remove hydrogel leachables and every 2-3 days during the culture duration. 
After lh, 1, 7, 14 and 2ld of culture, hydrogels were removed from the medium and 
immersed in PBS at 37°e for 30 min, then carefully blotted and weighed. Samples were 
prepared for biochemical assays (n=3-5), confocal fluorescence microscopy (n=3) and 
histology (n=2). 
Biochemical assays 
Samples reserved for biochemical assays were homogenized with a pellet grinder 
in 0.5 mL of sterile dd water and stored at -20oe. Prior to analyses, samples underwent 
three freeze-thaw-sonication cycles, with sonication performed on ice for 30 min. 
The hydrogel homogenates were analyzed for DNA content, alkaline phosphatase 
(ALP) activity, collagen and calcium content. The assays are described in more detail 
elsewhere 207-209. Prior to DNA and ALP analyses, samples were centrifuged at 4000 rpm 
for 5 min. Double-stranded DNA content was evaluated using the PicoGreen assay 
(Invitrogen, Eugene, OR) according to the manufacturer's instructions. Alkaline 
phosphatase (ALP) activity was evaluated with phosphatase substrate capsules in an 
alkaline buffer solution compared to serial dilutions of p-nitrophenol standards (all from 
Sigma) and absorbance was measured. After the DNA and ALP assays were performed, a 
volume of proteinase K solution equal to the remaining volume of the hydrogel 
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homogenates was added and samples were incubated at 56°C for 16h. The proteinase K 
solution was made of 1 mg/mL proteinase K, 0.01 mg/mL pepstatin A and 0.185 mg/mL 
iodoacetamide in a tris-EDTA buffer (6.055 mg/mL tris(hydroxymethylaminomethane) 
and 0.372 mglmL EDTA, pH=7.6). An aliquot of the digested sample was analyzed for 
hydroxyproline content as a measure of total collagen as previously described 210. For 
calcium analysis, a solution of acetic acid was added to the homogenates resulting in a 
final concentration of 0.5 N and samples were placed on a shaker at 120 rpm overnight to 
dissolve deposited salts. The assay was performed with a commercially available kit 
(Genzyme Diagnostics, Cambridge, MA) according to the manufacturer's instructions. 
For all assays, blank hydrogels from the same time points were used as controls to 
subtract the fluorescence or absorbance ofthe material from the sample readings. 
Confocal fluorescence microscopy 
Sections of 0.7 mm thickness were cut from the hydrogels in the transverse 
direction and incubated with 2 ~M calcein AM and 4 ~M ethidium homodimer-l 
according to the manufacturer's instructions (LivelDead viability/cytoxicity kit, 
Invitrogen, Eugene, OR). As a dead control, hydrogel sections were treated with 70% 
ethanol for 10 min prior to staining with LivelDead. Cell-free hydrogels were used as 
additional controls. Cellular viability and distribution were evaluated with a confocal 
fluorescence microscope (LSM 510 META, Carl Zeiss, Germany) using a lOx objective. 
Argon and helium-neon lasers were used for excitation at 488 and 543 nm, respectively, 
and emission filters at 505-526 and 612-644 nm were employed. 
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Histology 
Hydrogels were embedded in freezing medium (Histo-Prep, Fisher Scientific, Fair 
Lawn, NJ) and frozen at -20°C. As controls, blank hydrogels were processed and stained 
in the same manner. Frozen longitudinal sections of 8 ~m thickness were cut with a 
cryostat (Leica CM3050S). Sections were fixed in 10% formalin (Formalde-Fresh, 
Fisher), stained with Mayer hematoxylin and counterstained with Eosin-Y (Sigma). A 
second set of sections was stained with von Kossa reagent. Samples were immersed in 
1 % silver nitrate solution (Sigma) under a UV lamp at 365 nm for 30 min to visualize 
mineralization and counterstained with Eosin-Y. Sections were imaged with a light 
microscope (Eclipse E600, Nikon) and camera (3CCD Color Video Camera, Sony). 
Cell-free hydrogel mineralization 
Hydrogels were fabricated as outlined above and were soaked in complete 
osteogenic medium, osteogenic medium but without the addition of FBS, or simulated 
body fluid (SBF) which was prepared according to Kokubo and Takadama 211. Samples 
were incubated for 7, 14, 21 and 28d at 37°C, with medium changes every 2-3 days. A 
set of hydro gels was saved after fabrication and not immersed in any medium, serving as 
control. At time points, hydrogels were rinsed by immersing in dd water at 37°C for 30 
min. Gels were lyophilized, weighed, homogenized in 0.5 N acetic acid and analyzed for 
calcium as described above. 
124 
Statistical analysis 
Data from the studies were analyzed using single-factor analysis of variance 
(ANOVA) with a 95% confidence interval and Tukey's post hoc test. The global effects 
of the conditions in the swelling study in medium and PBS were evaluated with a two-
factor ANOV A and a 95% confidence interval. Data are reported as mean ± standard 
deviation. In the case of a sample size of n=2, data denote average ± range. 
Results 
Effect of initiator concentration and fabrication interval on hydrogel swelling 
Higher initiator concentrations and fabrication intervals resulted in increased 
hydrogel swelling (Figure V-I). The hydrogels fabricated with 20mM APS/TEMED and 
incubated for 30 min at 37°C showed the highest swelling ratio than all other groups (5.9 
±0.4). 
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Figure V-1: Swelling behavior of hydrogels with methacrylate end groups fabricated 
with different concentrations of APS/TEMED initiator system (10-20 mM) and 10-30 
min fabrication intervals at 37°C. Hydrogels were swollen in double distilled water for 
24h. Data are reported as mean ± standard deviation for a sample size ofn=3-4. Asterisk 
denotes statistical significance between groups from the same fabrication interval 
(p<0.05). 
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Hydrogel swelling below and above the LeST 
The lower critical transition temperature (LCST) of the acrylated formulation was 
26.5±0.5°C and the methacrylated formulation 12.7±OAoC as determined rheologically 
206 . The hydro gels swelled significantly when placed in water at 4°C after fabrication 
(Figure V -2). The acrylated hydrogels showed a swelling ratio of 17.8±0.9 whereas the 
methacrylated hydrogels had a ratio of 13.l±1.1. When the hydrogels were incubated in 
water at 37°C, the extent of swelling decreased, with the methacrylated hydrogels 
exhibiting significantly higher swelling than their acrylated analogs (6.1±0.6 and 3.9±0.2 
respectively). 
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Figure V-2: Swelling behavior of hydrogels with acrylate (n=4) and methacrylate (n=5) 
end groups at different temperatures. Hydrogels were weighed after fabrication, swollen 
in double-distilled (dd) water at 4°C (below their LCST) for 20h, weighed and swollen 
in dd water at 37°C (above their LCST) for 20h. Data are reported as mean ± standard 
deviation. Asterisk denotes statistically significant differences in swelling between 
formulations at each temperature (p<0.05). 
127 
Hydrogel degradation and swelling in cell culture medium and PBS 
Osteogenic cell culture medium: The swelling ratio of the acrylated hydrogels at 1 h 
was significantly higher than at 21 and 56 days (Figure V -3). For the methacrylated 
hydrogels, no significant changes were observed. As for the sol fraction, no increase that 
would indicate mass loss was noted. On the contrary, the sol fraction of the methacrylated 
hydrogels at 56d was significantly lower than that measured at the time points up to 14d 
(Figure V -4). 
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Figure V-3: Swelling behavior of hydrogels incubated in cell culture media or PBS at 
37°C over 8 weeks (n=2-5). Data are reported as mean ± standard deviation or as average 
± range in the case of n=2 (n=2 was obtained for acrylated gels in PBS at 1h and 
methacrylated gels in media at 28d). After equilibrium was reached at 1d, there were no 
significant differences in swelling between time points within each formulation. 
Acrylated hydrogels showed statistically significantly (p<0.05) lower swelling than their 
methacrylated analogs at all time points when incubated in PBS, whereas this effect was 
observed after 14d in media. Both acrylated and methacrylated hydrogels showed 
significantly (p<0.05) lower swelling in cell culture media compared to PBS. 
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PBS: After 1h, no significant differences in swelling were found for the acrylated 
hydrogels. The swelling at 1h was higher also for the methacrylated formulation as 
compared to the 28d time point. Acrylated hydro gels swelled less than the methacrylated 
counterparts at all time points. The sol fraction remained constant for both formulations 
over the course of 8 weeks. 
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Figure V-4: Sol fraction of hydrogels incubated in cell culture media or PBS at 37° C 
over 8 weeks (n=2-5). Data are reported as mean ± standard deviation or as average ± 
range in the case of n=2 (n=2 was obtained for acrylated gels in PBS at 1h and 
methacrylated gels in media at 28d). A statistically significant (p<0.05) decrease in sol 
fraction was observed for the methacrylated hydrogels cultured in media, whereas no 
differences were noted for all other groups. 
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Overall, the global effect of the incubation medium was statistically significant 
for both acrylated and methacrylated formulations, which each exhibited lower swelling 
in osteogenic cell cultured medium compared to PBS. 
MSC encapsulation in hydrogels 
The biochemical assays revealed a drop in DNA content after the first week for both 
formulations (Supplemental Figure V-I). Hematoxylin and eosin stained sections showed 
uniform cellular distribution throughout the hydro gels as seen at sections taken from the 
edge as well as from the center of the gels (Figure V -5). Cell viability was confirmed 
with LivelDead staining and confocal microscopy. Live cells could be observed 
throughout the hydrogel over the whole period of culture (Figure V -6). Due to the strong 
autofluorescence of the hydrogels at the wavelength used for the ethidium homodimer-l 
dye, imaging of the dead cells was not possible. Alkaline phosphatase was detected after 
lh in culture, peaked at ld for both formulations and decreased at later time points 
(Supplemental Figure V-II). The hydroxyproline assay did not show any collagen 
production for either formulation over the duration of the study. As for mineralization, 
calcium accumulation could be found for the cell-encapsulating hydro gels by day 7 
(Figure V-7). By day 21, however, cell-free hydrogels had also accumulated calcium at 
the same amount as the cell-laden hydrogels. Von Kossa staining confirmed the presence 
of calcium salts throughout the cell-laden hydrogels at 21d (supplemental Figure V -III). 
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Figure V-5: Hematoxylin and eosin stained longitudinal sections from the edge (left 
column, images a, c, e and g) and the center of MSC-Iaden hydrogels (right column, 
images b, d, f and h). Images a-d correspond to acrylated hydrogels after 1 (a-b) and 21 
(c-d) days of culture. Images e-h correspond to methacrylated hydrogels after 1 (e-f) and 
21 (g-h) days of culture. Cellular distribution could be observed throughout the hydrogels 
at both time points. Scale bar indicates 100 /-Lm. 
131 
Day 1 Day 7 Day 21 Dead control 
Ac 
MA 
Figure V-6: Fluorescence microscopy images of sections taken from the center of the 
hydrogels (thickness=0.7 mm) stained with LivelDead reagent at various time points. 
Live cells fluoresce green. Strong autofluorescence of the hydrogels at the wavelengths 
used for the dead dye component was observed and the images are therefore not shown. 
Included is a dead control treated with 70% ethanol for 10 min in which no live cells are 
observed. Acrylated hydrogels are denoted as Ac, whereas MA denotes methacrylated 
hydrogels. Scale bar indicates 1 00 ~m. 
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Figure V-7: Calcium content of hydro gels after culture in osteogenic media (n=3-5). (a) 
Calcium content per mg of "wet" hydrogel for mesenchymal stem cell-laden and cell-free 
hydrogels. (b) Calcium content per dry mass for cell-free hydrogels over 8 weeks. Due to 
experimental difficulties, the assay could not be performed on acrylated hydrogels on 
d28. Data are reported as mean ± standard deviation. Statistical significance between cell-
free formulations at time points is marked with an asterisk (p<0.05). 
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Cell-free hydrogel mineralization in different media 
Analysis for calcium showed significant accumulation in samples incubated with 
complete osteogenic medium over four weeks (Figure V -8). Hydrogels immersed in 
osteogenic medium without FBS as well as simulated body fluid did not yield 
mineralization. Scanning electron microscopy (SEM) coupled with an energy dispersive 
spectrometer (EDS) detector confirmed the presence of calcium and phosphorus in the 
hydrogels incubated with the FBS-containing medium over 28d but not in the two other 
groups (Supplemental figure V -IV). 
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Figure V-8: Calcium content of cell-free hydrogels immersed in complete osteogenic 
media, osteogenic media without fetal bovine serum (FBS) and simulated body fluid 
(SBF) at 37° Cover 4 weeks (n=4-6). Data are reported as mean ± standard deviation. 
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Discussion 
The fabrication of hydro gels via a dual gelation mechanism was the objective of 
this study. The macromers used as building blocks for the hydrogels were designed to 
employ a thermoresponsive domain and chemically crosslinkable (meth)acrylate end 
groups. The effect of the macromer structure (acrylate or methacrylate functional 
groups) on the properties of the resulting hydrogels was investigated. The swelling and 
degradation characteristics of the hydro gels were evaluated and these properties were 
examined with respect to mesenchymal stem cell viability and osteogenic potential upon 
encapsulation. 
Hydrogel swelling and degradation 
Hydrogel systems based on N-isopropylacrylamide show a temperature-
responsive swelling behavior. Among other factors, the swelling of these hydrogels is 
dependent on the hydrophilicity of the building blocks 155, l8l, the temperature 155,159,160 
and the pH 102, 202, 212 of the medium. Moreover, pNiP AAm, which has an LeST around 
32°e 69, has been shown to fully phase separate and precipitate at 37°e when it is in its 
linear, uncross linked state. 
The first study reported in this manuscript showed increased hydrogel swelling 
with longer fabrication times and increased initiator concentrations (Figure V-I). When 
the thermal initiator system was added in a final concentration of 20 mM and the 
hydrogels were formed for 30 minutes at 37°e, higher swelling ratios were observed as 
opposed to hydro gels fabricated for shorter intervals and/or lower initiator 
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concentrations. The phenomenon taking place at the incubation temperature of 37°C is a 
complex interplay between two kinetically independent mechanisms. Covalent 
crosslinking of the macromolecules takes place at the same time as those chains undergo 
a thermally-induced phase transition and collapse. The results suggest that longer 
fabrication intervals and higher initiator concentrations decreased the degree of 
pNiP AAm-driven collapse of the hydro gels during fabrication and also upon immersion 
in water at 37°C due to the network structure formed. 
The effect of temperature on the swelling of the hydro gels in water was 
investigated at temperatures below (4°C) and above (37°C) the LCST of the macromers 
(Figure V -2). The phenomenon of increased swelling below the transition temperature 
has been reported for NiPAAm-based systems and the water content has been shown to 
decrease as the temperature approaches and surpasses the LCST 155,159,160. In our studies, 
the swelling ratio for both hydrogel formulations was significantly higher at 4°C than at 
37°C and both hydrogel types expelled water when incubated at 37°C. An interesting 
observation was the higher temperature-responsiveness exhibited for the acrylated as 
opposed to the methacrylated formulation. Acrylated hydrogels swelled more than 
methacrylated at 4°C but exhibited higher shrinkage at 37°C. This may be attributed to 
the higher flexibility of the polymer chains having an acrylate end group. The additional 
methyl group of the methacrylated formulations may hinder the chains from fully 
undergoing the pNiP AAm-associated, temperature driven collapse above the LCST, and 
also from their complete hydration below the LCST. It is also likely that due to the higher 
hydrophobicity of the methacrylated chains a "skin layer" is formed at the polymer-
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aqueous medium interface which does not allow for water to be fully expelled from the 
interior of the hydrogel once the temperature increases 213. Factors that have been 
demonstrated to control the swelling behavior of hydrophilic, crosslinked hydrogel 
systems is the crosslinking density 65 or the difference between the incubation 
temperature and the LCST for uncrosslinked, pNiPAAm-based hydrogels 181. In the 
present system, there is an interrelation between the hydrophobic, pNiPAAm-driven 
chain aggregation and the presence of chemical crosslinks but these mechanisms do not 
seem to be the governing forces determining the hydrogel swelling. 
Further swelling and degradation studies were performed over eight weeks in 
complete osteogenic media and PBS. Lower swelling was observed for samples 
immersed in cell culture media as compared to PBS. The presence of solutes such as 
monosaccharides, amino acids and serum proteins in the complete osteogenic media may 
have decreased the affinity of the polymer chains for water, leading to higher shrinking. 
Additionally, the experimental temperature was above the hydro gels , LCST, which 
renders them more hydrophobic. This may facilitate protein adsorption from the serum on 
the hydro gels which can enhance hydrophobic interactions and lead to lower swelling. In 
both immersing media, the swelling at lh was generally different from subsequent time 
points suggesting that equilibrium had not yet been reached (Figure V -3). After this time 
point, there were no notable differences in swelling for each formulation, which is also 
consistent with the fact that no hydrogel degradation was observed (Figure V-4). 
Hydrogel chain degradation translates in an altered mesh structure and allows for changes 
in hydrogel swelling 204,214. The degradation of this hydrogel system is expected to occur 
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VIa hydrolysis of the ester bonds on pentaerythritol diacrylate monostearate and 
hydroxyethyl acrylate and its (meth)acrylated end groups. The present study showed that 
the time interval of eight weeks in vitro at 37°C was not sufficient for chain hydrolysis. 
As mentioned previously, the incubation temperature is above the LCST and the chains 
are partially dehydrated which likely shields esters from hydrolytic degradation. No mass 
loss was noted in the hydrogels incubated in PBS, as expressed with a constant sol 
fraction and dry mass. In addition, solid state NMR analysis (data not shown) did not 
detect any acidic compounds which would have resulted from ester hydrolysis. 
Mesenchymal stem cell encapsulation 
One advantage of an in situ forming hydrogel is the three-dimensional 
incorporation of cells and the potential control over their spatial distribution. In our 
system, homogeneous cellular distribution could be observed throughout the hydrogels 
for both formulations over three weeks of culture (Figure V -5). Hydrogel sections were 
taken both from the center and the edge of the hydrogels and stained with calcein AM 
and ethidium homodimer-l, markers for live and dead cells, respectively. Cells retained 
their viability over the entire period of the culture (Figure V -6). The cytocompatibility of 
the macromers for various times of crosslinking was evaluated in a previous study 206. In 
this case, the reaction rate of macromer crosslinking was fast enough as not to cause any 
significant adverse effects to encapsulated cells. The hydrogel systems presented in this 
study have relatively lower swelling ratios compared to purely hydrophilic systems. 
However, the water retained by both hydrogel types seemed to facilitate nutrient and 
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oxygen diffusion into the hydrogel as well as waste product removal, a fact evidenced by 
viable cells. 
One problem encountered in these studies was the incomplete DNA extraction 
from the cells and/or the gels. Double-stranded DNA could be detected until the first day 
of culture, but not at later time points. The presence of live cells however was confirmed 
with the LivelDead staining. Possible interactions of the material and matrix components 
with DNA as well as material autofluorescence were accounted for. Moreover, the 
presence of single- and double-stranded DNA was evaluated with the Oli-Green assay kit 
215 with minimal detection. Therefore, quantitative DNA assay results (included as 
Supplemental Figure V -I) may not accurately reflect the total number of live cells. 
Mesenchymal stem cells can undergo osteogenic differentiation when cultured in 
the presence of supplements such as dexamethasone 216. The osteogenic marker alkaline 
phosphatase (ALP) was detected when the cell-laden gels were cultured in complete 
osteogenic media (Supplemental Figure V -II). Calcium, another marker for osteogenic 
differentiation, was present in the cell-laden gels as early as after one week of culture. 
There did not seem to be an effect of (meth )acrylated end group on mineralization. At 14 
days, cell-free hydrogels had started to accumulate calcium, but at a significantly lower 
amount than cell-laden gels. At 21 days however, the calcium content of cell-laden and 
cell-free hydrogels was not statistically different (Figure V -7). Mineralized extracellular 
matrix has been shown to enhance osteogenic differentiation of mesenchymal stem cells 
210. Future in vivo studies could determine whether the mineralization of the hydrogels is 
a parameter that could further promote cell osteogenic differentiation in this system. 
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Cell -free hydrogel mineralization 
The mechanism of hydrogel mineralization was further evaluated with cell-free 
hydro gels immersed in three different mineralizing media, namely complete osteogenic 
medium, the same osteogenic medium but without the addition of fetal bovine serum 
(FBS) and simulated body fluid (SBF). SBF has a slightly higher concentration of 
calcium ions (2.5 mM) than the complete osteogenic medium (1.8 mM). Both contain 
inorganic phosphate (1 mM), whereas the latter also contains organic phosphate in the 
form of p-glycerol phosphate (10 mM). Hydrogel mineralization in the absence of cells 
generally occurs through the addition of anionic, calcium-binding functional groups on 
the polymer chains, the incorporation of inorganic particles into the matrix or the 
formation of nucleation sites by methods that mimic the physiological mineralization 
process 217. 
The results from the present studies indicate that the hydrogel mineralization here 
is mediated by the fetal bovine serum (Figure V -8). Fetal bovine serum can be extremely 
variable in composition 218 and often contains salts of calcium and phosphate 219,220. It 
has been reported that certain serum proteins act as calcification factors in the presence of 
adequate amounts of phosphate salts 221,222. There is also evidence in the literature that 
proteins found in serum exhibit endogenous alkaline phosphatase activity and can 
therefore hydrolyze the organic p-glycerol phosphate 223, 224. These reports are in 
agreement with our studies, which showed that serum in the presence of inorganic 
calcium and phosphate salts as well as high amounts of p-glycerol phosphate initiated 
mineralization. Since the incubation temperature of 37°C is higher than their LCST, the 
hydrogels are in a hydrophobic state, which likely favors protein adsorption from the 
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serum. This fact is evidenced also by the lower swelling observed in hydrogels immersed 
in complete osteogenic cell culture medium, which contains proteins, as opposed to 
samples immersed in PBS as previously discussed. Inorganic salts alone, as in SBF, or 
organic phosphate in the absence of serum, as in FBS-free media, did not result in 
hydrogel mineralization. 
Conclusions 
These studies demonstrated the fabrication of hydrogels with a dual solidification 
mechanism, namely lower critical solution behavior and covalent crosslinking. 
Parameters that control the swelling behavior of the hydrogels are the chemistry of the 
macromer end group (acrylate or methacrylate), the concentration of the initiator system 
used, the fabrication interval as well as the incubation temperature and medium. The 
hydrogels exhibited constant swelling and no degradation over an eight-week incubation 
period in vitro at 37°C. Encapsulated mesenchymal stem cells showed uniform 
distribution and viability throughout the hydrogels over a culture period of 21 days. 
Markers for cell osteogenic differentiation, alkaline phosphatase and calcium, were 
detected when the hydrogels were cultured in the presence of osteogenic supplements. 
Additionally, the hydrogels showed mineralization in the absence of cells but with 
addition of osteogenic cell culture medium supplemented with fetal bovine serum and p-
glycerol phosphate. 
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Supplemental figures-V: (I) and (II): Biochemical assays performed on cell-laden 
hydrogels cultured in osteogenic media over 21d (n=3-5). Assay readings were corrected 
for with blank hydrogels. (I) DNA content as determined with PicoGreen reagent. (II) 
Alkaline phosphatase activity. (III) Histological sections of cell-laden hydrogels stained 
with von Kossa reagent. Acrylated and methacrylated hydrogel sections after one-day and 
21-day culture are presented. (N) Energy dispersive spectra of cell-free hydrogels 
immersed for 28 days in (a) complete osteogenic media containing FBS, (b) FBS-free 
media, (c) SBF. Samples were sputter-coated in gold prior to SEM-EDS analysis. The 
signals for carbon and nitrogen derive from the polymer. Calcium and phosphorus are 
only detected for the samples in FBS-containing media. The calcium to phosphorus ratio 
for these samples was 1.IO±O.23 and was determined for n=3. 
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CHAPTER VI 
SUMMARY AND OVERALL CONCLUSIONS 
This work focused on the synthesis of amphiphilic, thermoresponsive macromers 
and the fabrication of hydrogels that form in situ in response to two solidification 
mechanisms, a lower critical phase separation phenomenon and covalent crosslinking. 
The potential of these hydro gels for cell delivery was investigated in a series of 
cytocompatibility studies and with the encapsulation of mesenchymal stem cells. 
The first aim of the work was the synthesis of amphiphilic, thermally responsive 
macromers with chemically modifiable groups which would allow for the addition of 
covalently crosslinkable moieties. Structure-property correlations for thermo gelling 
macromers were established and the hydrophilic-hydrophobic balance was found to be an 
important criterion in controlling the gelation temperature of macromer solutions and 
thermodynamic stability of the resulting gels. As a next step, the free hydroxyls on the 
macromers were modified towards acrylate or methacrylate groups. A second gelation 
mechanism could be achieved by covalently linking these groups with the addition of a 
free radical thermal initiator system. The combination of physical thermogelation and 
thermally induced chemical crosslinking was shown to yield hydrogels with higher 
viscosity and stability. 
The second aim of the work was to evaluate the cytocompatibility of the 
macromers. A first series of studies examined the cytocompatibility of unmodified 
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thermogelling macromers. Macromers of different molecular compositions and molecular 
weights were tested in vitro for their effect on cell viability in a hydrogel leachables as 
well as in a direct contact assay. An additional parameter investigated was the effect of 
the lower critical solution temperature on cytocompatibility. Overall, high cell viabilities 
were observed over a 24-h time interval. A second series of studies focused on the 
cytocompatibility characterization of macromers modified with the addition of 
(meth)acrylate groups. The effect of the (meth)acrylate derivatization on the toxicity of 
uncrosslinked macromers was examined and it was determined that cell viability 
decreased significantly after a 6-h exposure period for most formulations. In addition to 
the time-dependent effect, a dose-dependent effect of the macromers on cell viability was 
pronounced. Increased degrees of modification were shown to decrease the thermal 
transition temperature as well as the cytocompatibility of the macromers. These studies 
gave important information on the parameters that allow for high cell viability during 
encapsulation in these hydrogels, such as time frame for crosslinking completion. 
The third and last aim was the fabrication of hydro gels from the thermoresponsive 
and chemically crosslinkable macromers. The swelling behavior of the hydrogels was 
characterized and it was found to be controlled by the chemistry of the macromer end 
group (acrylate or methacrylate), the concentration of the initiator system used, the 
fabrication interval as well as the incubation temperature and medium. When the 
hydro gels were incubated in vitro at 37°C, constant swelling and no degradation were 
observed over eight weeks. Mesenchymal stem cells were encapsulated and the hydrogels 
were cultured with osteogenic supplements over 21 days. Cells showed uniform 
distribution and viability throughout the hydrogels over the duration of the culture. 
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Markers for cell osteogenic differentiation, alkaline phosphatase and calcium, were 
detected. Interestingly, cell-free hydrogels showed mineralization in the presence of fetal 
bovine serum and p-glycerol phosphate when cultured in vitro at 37°e. 
Overall, these studies demonstrated the successful synthesis and characterization 
of a thermoresponsive and chemically crosslinkable hydrogel system with controllable 
properties. These hydrogels may be hold promise as injectable, minimally invasive 
carriers for cells into a defect, encompassing a mild solidification process which would 
not cause damage to cells and bioactive molecules to be delivered as well as to the 
surrounding tissues. The design criteria in terms of hydrogel mechanical properties and 
hydrogel stability were realized by chemically crosslinking the hydrogel in addition to its 
physical thermogelation. The cytocompatibility of the macromers and the hydrogel 
system was found to be high and correlations between structure and properties were 
established. The biodegradation of the hydrogels is a parameter that may need to be 
optimized for future applications. In these studies, no degradation was observed in vitro 
over a period of eight weeks. The desired rate of biodegradation is strongly application 
dependent, but ideally, scaffold degradation should start taking place during the time cells 
differentiate and produce extracellular matrix. 
In order to tailor the degradation rate of the polymer, the hydrophilicity of the 
hydrogels is one parameter that could be modified. This could be achieved by the 
addition of more hydrophilic monomers in the polymer. An increase in the overaU 
hydrophilicity is likely to influence the swelling characteristics of the hydro gels, and the 
contact with the aqueous medium could accelerate degradation. This factor may be 
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further beneficial in tenns of diffusional properties and cell encapsulation. Another 
strategy for future studies could be the incorporation of more hydrolytically labile bonds 
in the backbone of the polymer which would enhance the degradability of the hydrogels. 
However, the properties of the resulting macromers are expected to change significantly 
with any of these modifications in composition. A new set of studies to characterize the 
thennal gelation and stability properties would be necessary, as well as the 
characterization of the hydro gels fabricated with these macromers. 
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